| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.856 | 0.002 | 0.956 | Estrogen antagonist | 0.787 0.003 DBMET00029 0.372 0.005 DBMET02703 0.893 0.002 DBMET00032 0.871 0.002 DBMET00030 0.749 0.003 DBMET02699 0.822 0.003 DBMET01044 0.813 0.003 DBMET02714 0.216 0.011 DBMET02705 0.277 0.007 DBMET02704 0.651 0.003 DBMET00737 0.439 0.004 DBMET02702 0.651 0.003 DBMET02700 0.845 0.002 DBMET02719 0.872 0.002 DBMET02715 0.956 0.001 DBMET02716 0.608 0.004 DBMET02717 | DBMET02716 | |
| 0.83 | 0.007 | 0.865 | Caspase 9 stimulant | 0.767 0.016 DBMET00029 0.656 0.029 DBMET02703 0.612 0.034 DBMET00032 0.849 0.005 DBMET00030 0.489 0.064 DBMET02699 0.8 0.011 DBMET01044 0.779 0.014 DBMET02714 0.776 0.014 DBMET02705 0.342 0.152 DBMET02704 0.373 0.128 DBMET00737 0.779 0.014 DBMET02702 0.396 0.114 DBMET02700 0.81 0.01 DBMET02719 0.829 0.008 DBMET02715 0.865 0.004 DBMET02716 0.858 0.005 DBMET02717 | DBMET02716 | |
| 0.803 | 0.004 | 0.927 | Aldehyde oxidase inhibitor | 0.539 0.027 DBMET00029 0.889 0.003 DBMET02703 0.389 0.049 DBMET00032 0.918 0.003 DBMET00030 0.411 0.045 DBMET02699 0.672 0.01 DBMET01044 0.618 0.017 DBMET02714 0.317 0.062 DBMET02705 0.568 0.023 DBMET02704 0.368 0.052 DBMET00737 0.167 0.125 DBMET02700 0.733 0.006 DBMET02719 0.927 0.003 DBMET02715 0.867 0.004 DBMET02716 0.175 0.12 DBMET02717 | DBMET02715 | |
| 0.692 | 0.005 | 0.9 | Vasodilator, coronary | 0.648 0.005 DBMET00029 0.679 0.005 DBMET02703 0.433 0.026 DBMET00032 0.697 0.005 DBMET00030 0.38 0.042 DBMET02699 0.651 0.005 DBMET01044 0.625 0.007 DBMET02714 0.9 0.003 DBMET02705 0.417 0.03 DBMET02704 0.407 0.033 DBMET00737 0.885 0.003 DBMET02702 0.386 0.04 DBMET02700 0.629 0.006 DBMET02719 0.48 0.018 DBMET02715 0.485 0.018 DBMET02716 0.725 0.004 DBMET02717 | DBMET02705 | |
| 0.663 | 0.004 | 0.736 | Growth factor agonist | 0.652 0.004 DBMET00029 0.299 0.015 DBMET02703 0.425 0.005 DBMET00032 0.554 0.004 DBMET00030 0.39 0.005 DBMET02699 0.55 0.004 DBMET01044 0.587 0.004 DBMET02714 0.273 0.023 DBMET02705 0.191 0.073 DBMET02704 0.299 0.015 DBMET00737 0.348 0.009 DBMET02702 0.382 0.006 DBMET02700 0.513 0.004 DBMET02719 0.68 0.004 DBMET02715 0.736 0.003 DBMET02716 0.37 0.007 DBMET02717 | DBMET02716 | |
| 0.605 | 0.012 | 0.749 | Spasmolytic | 0.525 0.02 DBMET00029 0.664 0.008 DBMET02703 0.228 0.101 DBMET00032 0.646 0.009 DBMET00030 0.578 0.015 DBMET01044 0.383 0.044 DBMET02714 0.749 0.005 DBMET02705 0.606 0.012 DBMET02704 0.567 0.016 DBMET00737 0.672 0.008 DBMET02702 0.381 0.044 DBMET02700 0.433 0.034 DBMET02719 0.368 0.047 DBMET02715 0.318 0.063 DBMET02716 0.436 0.033 DBMET02717 | DBMET02705 | |
| 0.578 | 0.007 | 0.578 | Vasodilator | 0.551 0.009 DBMET00029 0.423 0.019 DBMET02703 0.349 0.033 DBMET00032 0.559 0.008 DBMET00030 0.356 0.031 DBMET02699 0.535 0.009 DBMET01044 0.569 0.007 DBMET02714 0.531 0.01 DBMET02705 0.259 0.064 DBMET02704 0.385 0.026 DBMET00737 0.545 0.009 DBMET02702 0.357 0.031 DBMET02700 0.552 0.008 DBMET02719 0.53 0.01 DBMET02715 0.535 0.009 DBMET02716 0.545 0.009 DBMET02717 | ||
| 0.572 | 0.004 | 0.579 | Anesthetic local | 0.474 0.005 DBMET00029 0.579 0.004 DBMET02703 0.199 0.033 DBMET00032 0.517 0.004 DBMET00030 0.197 0.033 DBMET02699 0.431 0.005 DBMET01044 0.302 0.012 DBMET02714 0.149 0.049 DBMET02705 0.297 0.013 DBMET02704 0.16 0.045 DBMET00737 0.218 0.028 DBMET02700 0.274 0.015 DBMET02719 0.291 0.013 DBMET02715 0.21 0.03 DBMET02716 | DBMET02703 | |
| 0.534 | 0.001 | 0.841 | Estrogen-related receptor gamma agonist | 0.468 0.001 DBMET00029 0.07 0.002 DBMET02703 0.052 0.003 DBMET00032 0.841 0.001 DBMET00030 0.045 0.003 DBMET02699 0.735 0.001 DBMET01044 0.086 0.002 DBMET02714 0.028 0.005 DBMET02704 0.047 0.003 DBMET00737 0.022 0.008 DBMET02702 0.061 0.002 DBMET02700 0.311 0.001 DBMET02719 0.126 0.002 DBMET02715 0.27 0.001 DBMET02716 | DBMET00030 | |
| 0.521 | 0.001 | 0.657 | Estrogen-related receptor beta agonist | 0.308 0.001 DBMET00029 0.289 0.002 DBMET02703 0.235 0.002 DBMET00032 0.657 0 DBMET00030 0.215 0.002 DBMET02699 0.432 0.001 DBMET01044 0.258 0.002 DBMET02714 0.136 0.005 DBMET02705 0.173 0.003 DBMET02704 0.224 0.002 DBMET00737 0.123 0.009 DBMET02702 0.17 0.003 DBMET02700 0.364 0.001 DBMET02719 0.303 0.001 DBMET02715 0.349 0.001 DBMET02716 0.108 0.017 DBMET02717 | DBMET00030 | |
| 0.506 | 0 | 0.913 | Estrogen-related receptor beta antagonist | 0.41 0.001 DBMET00029 0.227 0.001 DBMET02703 0.405 0.001 DBMET00032 0.474 0.001 DBMET00030 0.379 0.001 DBMET02699 0.383 0.001 DBMET01044 0.469 0.001 DBMET02714 0.127 0.002 DBMET02705 0.192 0.001 DBMET02704 0.296 0.001 DBMET00737 0.192 0.001 DBMET02702 0.282 0.001 DBMET02700 0.438 0.001 DBMET02719 0.539 0 DBMET02715 0.913 0 DBMET02716 0.26 0.001 DBMET02717 | DBMET02716 | |
| 0.503 | 0.004 | 0.83 | Estrogen agonist | 0.415 0.004 DBMET00029 0.118 0.014 DBMET02703 0.353 0.004 DBMET00032 0.565 0.003 DBMET00030 0.432 0.004 DBMET02699 0.499 0.004 DBMET01044 0.455 0.004 DBMET02714 0.11 0.015 DBMET02705 0.137 0.012 DBMET02704 0.597 0.003 DBMET00737 0.293 0.005 DBMET02702 0.518 0.003 DBMET02700 0.529 0.003 DBMET02719 0.558 0.003 DBMET02715 0.83 0.002 DBMET02716 0.467 0.004 DBMET02717 | DBMET02716 | |
| 0.46 | 0.004 | 0.815 | Estrogen receptor beta antagonist | 0.36 0.004 DBMET00029 0.147 0.016 DBMET02703 0.302 0.005 DBMET00032 0.568 0.003 DBMET00030 0.31 0.005 DBMET02699 0.485 0.004 DBMET01044 0.399 0.004 DBMET02714 0.103 0.059 DBMET02705 0.123 0.029 DBMET02704 0.283 0.005 DBMET00737 0.132 0.022 DBMET02702 0.265 0.006 DBMET02700 0.53 0.004 DBMET02719 0.509 0.004 DBMET02715 0.815 0.002 DBMET02716 0.174 0.012 DBMET02717 | DBMET02716 | |
| 0.457 | 0.028 | 0.701 | Caspase 3 stimulant | 0.428 0.036 DBMET00029 0.236 0.125 DBMET02703 0.306 0.076 DBMET00032 0.472 0.025 DBMET00030 0.371 0.053 DBMET02699 0.445 0.031 DBMET01044 0.44 0.032 DBMET02714 0.336 0.064 DBMET02705 0.215 0.148 DBMET00737 0.43 0.035 DBMET02702 0.268 0.098 DBMET02700 0.456 0.028 DBMET02719 0.49 0.022 DBMET02715 0.701 0.005 DBMET02716 0.554 0.014 DBMET02717 | DBMET02716 | |
| 0.44 | 0.021 | 0.613 | DNA damaging | 0.435 0.021 DBMET00029 0.238 0.087 DBMET02703 0.613 0.008 DBMET00032 0.455 0.019 DBMET00030 0.28 0.065 DBMET02699 0.45 0.019 DBMET01044 0.49 0.015 DBMET02714 0.336 0.045 DBMET02705 0.25 0.08 DBMET00737 0.482 0.015 DBMET02702 0.265 0.072 DBMET02700 0.505 0.013 DBMET02719 0.436 0.021 DBMET02715 0.42 0.024 DBMET02716 0.449 0.019 DBMET02717 | DBMET00032 | |
| 0.411 | 0.005 | 0.414 | Alpha 2b adrenoreceptor antagonist | 0.414 0.005 DBMET00029 0.123 0.055 DBMET02703 0.179 0.029 DBMET00032 0.351 0.006 DBMET00030 0.107 0.069 DBMET02699 0.354 0.006 DBMET01044 0.304 0.009 DBMET02714 0.135 0.047 DBMET02700 0.258 0.013 DBMET02719 0.151 0.038 DBMET02715 0.236 0.017 DBMET02716 | DBMET00029 | |
| 0.391 | 0.004 | 0.663 | Estrogen receptor alpha antagonist | 0.174 0.009 DBMET00029 0.125 0.017 DBMET02703 0.118 0.019 DBMET00032 0.663 0.003 DBMET00030 0.173 0.01 DBMET02699 0.374 0.004 DBMET01044 0.153 0.011 DBMET02714 0.083 0.044 DBMET02704 0.136 0.014 DBMET00737 0.108 0.023 DBMET02700 0.338 0.004 DBMET02719 0.335 0.004 DBMET02715 0.5 0.003 DBMET02716 0.072 0.064 DBMET02717 | DBMET00030 | |
| 0.393 | 0.023 | 0.393 | Psychostimulant | 0.363 0.029 DBMET00029 0.359 0.03 DBMET02703 0.392 0.024 DBMET00030 0.361 0.029 DBMET01044 0.236 0.064 DBMET02714 0.352 0.031 DBMET02705 0.37 0.028 DBMET02702 0.234 0.065 DBMET02719 0.171 0.099 DBMET02715 0.239 0.063 DBMET02716 0.248 0.059 DBMET02717 | ||
| 0.406 | 0.053 | 0.524 | Vasodilator, peripheral | 0.292 0.101 DBMET00029 0.507 0.026 DBMET02703 0.412 0.051 DBMET00030 0.298 0.098 DBMET01044 0.524 0.024 DBMET02705 0.204 0.171 DBMET02704 0.27 0.113 DBMET02702 0.313 0.091 DBMET02715 0.215 0.159 DBMET02716 0.2 0.176 DBMET02717 | DBMET02705 | |
| 0.348 | 0.009 | 0.356 | Acetylcholine M1 receptor antagonist | 0.278 0.019 DBMET00029 0.218 0.035 DBMET02703 0.149 0.075 DBMET00032 0.356 0.008 DBMET00030 0.135 0.089 DBMET02699 0.283 0.018 DBMET01044 0.239 0.028 DBMET02714 0.183 0.05 DBMET00737 0.145 0.079 DBMET02700 0.245 0.026 DBMET02719 0.215 0.036 DBMET02715 0.26 0.023 DBMET02716 | DBMET00030 | |
| 0.334 | 0.004 | 0.337 | 5 Hydroxytryptamine 3E antagonist | 0.337 0.004 DBMET00029 0.263 0.011 DBMET02703 0.22 0.037 DBMET00032 0.263 0.011 DBMET00030 0.249 0.016 DBMET02699 0.266 0.01 DBMET01044 0.317 0.004 DBMET02714 0.258 0.013 DBMET02704 0.212 0.045 DBMET00737 0.261 0.012 DBMET02700 0.248 0.017 DBMET02719 0.191 0.078 DBMET02715 0.183 0.097 DBMET02716 | DBMET00029 | |
| 0.351 | 0.021 | 0.392 | P-glycoprotein inhibitor | 0.303 0.028 DBMET00029 0.238 0.045 DBMET02703 0.183 0.077 DBMET00032 0.319 0.026 DBMET00030 0.168 0.092 DBMET02699 0.281 0.033 DBMET01044 0.295 0.03 DBMET02714 0.194 0.068 DBMET02705 0.153 0.112 DBMET02704 0.154 0.111 DBMET00737 0.249 0.042 DBMET02702 0.171 0.088 DBMET02700 0.273 0.035 DBMET02719 0.392 0.017 DBMET02715 0.375 0.019 DBMET02716 0.278 0.034 DBMET02717 | DBMET02715 | |
| 0.326 | 0.003 | 0.326 | Phosphodiesterase 1B inhibitor | 0.132 0.009 DBMET00029 0.07 0.03 DBMET02703 0.096 0.016 DBMET00032 0.278 0.004 DBMET00030 0.103 0.014 DBMET02699 0.104 0.013 DBMET01044 0.156 0.006 DBMET02714 0.079 0.023 DBMET00737 0.121 0.01 DBMET02719 0.177 0.005 DBMET02715 0.191 0.005 DBMET02716 | ||
| 0.324 | 0.003 | 0.324 | Phosphodiesterase 1C inhibitor | 0.14 0.005 DBMET00029 0.087 0.015 DBMET02703 0.109 0.008 DBMET00032 0.288 0.003 DBMET00030 0.113 0.008 DBMET02699 0.121 0.006 DBMET01044 0.16 0.004 DBMET02714 0.103 0.009 DBMET00737 0.139 0.005 DBMET02719 0.184 0.004 DBMET02715 0.184 0.004 DBMET02716 | ||
| 0.309 | 0.005 | 0.422 | Phosphodiesterase 4A inhibitor | 0.235 0.005 DBMET00029 0.046 0.038 DBMET02703 0.199 0.007 DBMET00032 0.221 0.006 DBMET00030 0.197 0.007 DBMET02699 0.166 0.009 DBMET01044 0.284 0.005 DBMET02714 0.071 0.024 DBMET00737 0.086 0.019 DBMET02700 0.198 0.007 DBMET02719 0.394 0.004 DBMET02715 0.422 0.004 DBMET02716 0.089 0.018 DBMET02717 | DBMET02716 | |
| 0.302 | 0.005 | 0.302 | Phosphodiesterase I inhibitor | 0.153 0.017 DBMET00029 0.103 0.041 DBMET02703 0.109 0.035 DBMET00032 0.275 0.005 DBMET00030 0.198 0.011 DBMET02699 0.13 0.023 DBMET01044 0.219 0.009 DBMET02714 0.092 0.055 DBMET00737 0.19 0.012 DBMET02719 0.207 0.01 DBMET02715 0.248 0.007 DBMET02716 | ||
| 0.295 | 0.004 | 0.323 | Histamine H2 receptor antagonist | 0.323 0.003 DBMET00029 0.107 0.029 DBMET02703 0.122 0.02 DBMET00032 0.202 0.005 DBMET00030 0.116 0.023 DBMET02699 0.226 0.005 DBMET01044 0.218 0.005 DBMET02714 0.081 0.064 DBMET00737 0.132 0.015 DBMET02700 0.148 0.01 DBMET02719 0.12 0.021 DBMET02715 0.111 0.026 DBMET02716 | DBMET00029 | |
| 0.346 | 0.057 | 0.611 | 5 Hydroxytryptamine release stimulant | 0.492 0.029 DBMET00029 0.409 0.044 DBMET02703 0.201 0.12 DBMET00032 0.364 0.053 DBMET00030 0.233 0.098 DBMET02699 0.506 0.026 DBMET01044 0.572 0.017 DBMET02714 0.203 0.119 DBMET02705 0.3 0.07 DBMET02702 0.169 0.155 DBMET02700 0.585 0.016 DBMET02719 0.386 0.049 DBMET02715 0.611 0.013 DBMET02716 0.43 0.04 DBMET02717 | DBMET02716 | |
| 0.289 | 0.004 | 0.367 | CYP2A6 inhibitor | 0.275 0.004 DBMET00029 0.138 0.02 DBMET02703 0.139 0.02 DBMET00032 0.219 0.005 DBMET00030 0.107 0.032 DBMET02699 0.21 0.006 DBMET01044 0.367 0.003 DBMET02714 0.069 0.061 DBMET02704 0.111 0.031 DBMET02700 0.281 0.004 DBMET02719 0.124 0.025 DBMET02715 0.239 0.005 DBMET02716 | DBMET02714 | |
| 0.37 | 0.09 | 0.545 | Histamine release inhibitor | 0.211 0.189 DBMET00029 0.457 0.046 DBMET02703 0.424 0.063 DBMET00030 0.269 0.142 DBMET01044 0.235 0.167 DBMET02714 0.545 0.017 DBMET02705 0.307 0.12 DBMET02704 0.303 0.122 DBMET00737 0.421 0.065 DBMET02702 0.3 0.124 DBMET02719 0.499 0.029 DBMET02715 0.429 0.061 DBMET02716 0.524 0.022 DBMET02717 | DBMET02705 | |
| 0.298 | 0.033 | 0.373 | Anesthetic general | 0.192 0.079 DBMET00029 0.279 0.039 DBMET02703 0.342 0.025 DBMET00030 0.226 0.061 DBMET01044 0.212 0.068 DBMET02714 0.37 0.021 DBMET02705 0.206 0.071 DBMET02702 0.245 0.053 DBMET02719 0.373 0.02 DBMET02715 0.277 0.039 DBMET02716 0.261 0.045 DBMET02717 | DBMET02715 | |
| 0.263 | 0.001 | 0.506 | Estrogen-related receptor gamma antagonist | 0.137 0.001 DBMET00029 0.096 0.001 DBMET02703 0.086 0.001 DBMET00032 0.506 0 DBMET00030 0.079 0.002 DBMET02699 0.253 0.001 DBMET01044 0.088 0.001 DBMET02714 0.032 0.012 DBMET02705 0.069 0.002 DBMET02704 0.115 0.001 DBMET00737 0.036 0.008 DBMET02702 0.106 0.001 DBMET02700 0.116 0.001 DBMET02719 0.109 0.001 DBMET02715 0.107 0.001 DBMET02716 | DBMET00030 | |
| 0.347 | 0.087 | 0.578 | GABA C receptor rho-3 antagonist | 0.365 0.078 DBMET00029 0.245 0.159 DBMET00032 0.384 0.069 DBMET00030 0.213 0.191 DBMET02699 0.402 0.06 DBMET01044 0.399 0.062 DBMET02714 0.434 0.048 DBMET02719 0.359 0.081 DBMET02715 0.578 0.01 DBMET02716 | DBMET02716 | |
| 0.378 | 0.124 | 0.661 | Apoptosis agonist | 0.382 0.123 DBMET00029 0.432 0.099 DBMET00030 0.432 0.099 DBMET01044 0.359 0.134 DBMET02714 0.561 0.058 DBMET02705 0.581 0.054 DBMET02702 0.331 0.151 DBMET02700 0.42 0.104 DBMET02719 0.429 0.1 DBMET02715 0.512 0.071 DBMET02716 0.661 0.037 DBMET02717 | DBMET02717 | |
| 0.256 | 0.003 | 0.366 | Beta 3 adrenoreceptor antagonist | 0.289 0.003 DBMET00029 0.233 0.004 DBMET02703 0.109 0.012 DBMET00032 0.332 0.002 DBMET00030 0.125 0.009 DBMET02699 0.366 0.002 DBMET01044 0.165 0.005 DBMET02714 0.11 0.012 DBMET02704 0.137 0.007 DBMET00737 0.068 0.038 DBMET02702 0.155 0.005 DBMET02700 0.226 0.004 DBMET02719 0.185 0.004 DBMET02715 0.195 0.004 DBMET02716 | DBMET01044 | |
| 0.256 | 0.004 | 0.256 | Sphingomyelinase inhibitor | 0.219 0.007 DBMET00029 0.255 0.004 DBMET02703 0.119 0.042 DBMET00032 0.227 0.005 DBMET00030 0.103 0.056 DBMET02699 0.192 0.011 DBMET01044 0.218 0.007 DBMET02714 0.249 0.004 DBMET02705 0.159 0.021 DBMET02704 0.122 0.04 DBMET00737 0.176 0.015 DBMET02702 0.13 0.034 DBMET02700 0.191 0.011 DBMET02719 0.163 0.019 DBMET02715 0.135 0.032 DBMET02716 0.123 0.039 DBMET02717 | ||
| 0.261 | 0.02 | 0.266 | Nav1.2 sodium channel blocker | 0.216 0.029 DBMET00029 0.266 0.019 DBMET02703 0.208 0.032 DBMET00030 0.173 0.045 DBMET01044 0.177 0.044 DBMET02714 0.191 0.038 DBMET02704 0.219 0.028 DBMET00737 0.124 0.079 DBMET02700 0.136 0.067 DBMET02719 | DBMET02703 | |
| 0.237 | 0.003 | 0.237 | Phosphodiesterase 1A inhibitor | 0.13 0.006 DBMET00029 0.058 0.046 DBMET02703 0.09 0.012 DBMET00032 0.173 0.004 DBMET00030 0.09 0.012 DBMET02699 0.088 0.013 DBMET01044 0.126 0.006 DBMET02714 0.073 0.021 DBMET00737 0.086 0.014 DBMET02719 0.111 0.008 DBMET02715 0.139 0.005 DBMET02716 | ||
| 0.263 | 0.039 | 0.298 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.244 0.045 DBMET00029 0.232 0.051 DBMET00030 0.221 0.057 DBMET01044 0.22 0.057 DBMET02714 0.203 0.07 DBMET02719 0.223 0.056 DBMET02715 0.298 0.03 DBMET02716 | DBMET02716 | |
| 0.223 | 0.013 | 0.223 | Nav1.6 sodium channel blocker | 0.18 0.028 DBMET00029 0.196 0.021 DBMET02703 0.18 0.028 DBMET00030 0.149 0.055 DBMET01044 0.147 0.057 DBMET02714 0.133 0.077 DBMET02704 0.115 0.104 DBMET02719 0.123 0.091 DBMET02716 | ||
| 0.216 | 0.021 | 0.224 | Acetylcholine muscarinic antagonist | 0.146 0.046 DBMET00029 0.131 0.058 DBMET02703 0.224 0.019 DBMET00030 0.152 0.043 DBMET01044 0.117 0.07 DBMET02714 0.098 0.094 DBMET02704 0.107 0.082 DBMET00737 0.121 0.065 DBMET02719 0.113 0.075 DBMET02715 0.142 0.049 DBMET02716 | DBMET00030 | |
| 0.218 | 0.023 | 0.218 | 5 Hydroxytryptamine 2B antagonist | 0.135 0.048 DBMET00029 0.151 0.04 DBMET00030 0.102 0.081 DBMET01044 0.121 0.06 DBMET02714 0.106 0.076 DBMET02716 | ||
| 0.201 | 0.013 | 0.215 | Calcium antagonist | 0.105 0.044 DBMET00029 0.215 0.012 DBMET02703 0.113 0.039 DBMET00030 0.123 0.033 DBMET02714 0.096 0.051 DBMET02704 | DBMET02703 | |
| 0.201 | 0.014 | 0.201 | Alpha 2a adrenoreceptor antagonist | 0.196 0.014 DBMET00029 0.18 0.017 DBMET00030 0.176 0.018 DBMET01044 0.166 0.019 DBMET02714 0.146 0.023 DBMET02719 0.121 0.029 DBMET02716 | ||
| 0.192 | 0.006 | 0.192 | Acetylcholine M4 receptor antagonist | 0.107 0.023 DBMET00029 0.074 0.052 DBMET00032 0.119 0.018 DBMET00030 0.072 0.054 DBMET01044 0.088 0.039 DBMET02714 0.092 0.035 DBMET02715 0.088 0.039 DBMET02716 | ||
| 0.231 | 0.046 | 0.294 | Insulin sensitizer | 0.244 0.038 DBMET00029 0.294 0.017 DBMET02703 0.163 0.115 DBMET00032 0.242 0.039 DBMET00030 0.151 0.131 DBMET02699 0.255 0.032 DBMET01044 0.246 0.037 DBMET02714 0.245 0.037 DBMET02705 0.186 0.088 DBMET02704 0.179 0.097 DBMET00737 0.249 0.035 DBMET02702 0.191 0.083 DBMET02700 0.257 0.031 DBMET02719 0.232 0.046 DBMET02715 0.223 0.052 DBMET02716 0.219 0.055 DBMET02717 | DBMET02703 | |
| 0.207 | 0.022 | 0.242 | Nav1.3 sodium channel blocker | 0.183 0.031 DBMET00029 0.242 0.015 DBMET02703 0.155 0.044 DBMET00030 0.135 0.06 DBMET01044 0.101 0.096 DBMET02714 | DBMET02703 | |
| 0.283 | 0.102 | 0.649 | Cholesterol antagonist | 0.299 0.092 DBMET00029 0.361 0.06 DBMET02703 0.188 0.176 DBMET00032 0.329 0.074 DBMET00030 0.337 0.07 DBMET02699 0.346 0.066 DBMET01044 0.275 0.108 DBMET02714 0.64 0.014 DBMET02705 0.271 0.111 DBMET02704 0.405 0.048 DBMET00737 0.626 0.015 DBMET02702 0.236 0.136 DBMET02700 0.322 0.078 DBMET02719 0.355 0.062 DBMET02715 0.37 0.057 DBMET02716 0.649 0.013 DBMET02717 | DBMET02717 | |
| 0.183 | 0.005 | 0.183 | Acetylcholine M5 receptor antagonist | 0.123 0.012 DBMET00029 0.071 0.03 DBMET02703 0.059 0.044 DBMET00032 0.158 0.007 DBMET00030 0.107 0.016 DBMET01044 0.086 0.022 DBMET02714 0.073 0.028 DBMET02719 0.088 0.021 DBMET02715 0.1 0.017 DBMET02716 | ||
| 0.207 | 0.03 | 0.207 | Cholinergic antagonist | 0.154 0.05 DBMET00029 0.113 0.081 DBMET02703 0.203 0.031 DBMET00030 0.151 0.052 DBMET01044 0.123 0.071 DBMET02714 0.12 0.073 DBMET02719 0.111 0.082 DBMET02716 | ||
| 0.21 | 0.033 | 0.305 | Bone formation stimulant | 0.177 0.043 DBMET00029 0.145 0.063 DBMET02703 0.244 0.026 DBMET00030 0.21 0.033 DBMET01044 0.232 0.028 DBMET02714 0.136 0.071 DBMET02705 0.127 0.079 DBMET00737 0.164 0.049 DBMET02702 0.155 0.055 DBMET02700 0.261 0.023 DBMET02719 0.261 0.023 DBMET02715 0.305 0.016 DBMET02716 0.187 0.039 DBMET02717 | DBMET02716 | |
| 0.2 | 0.031 | 0.2 | Acetylcholine antagonist | 0.147 0.051 DBMET00029 0.106 0.084 DBMET02703 0.195 0.032 DBMET00030 0.144 0.053 DBMET01044 0.115 0.075 DBMET02714 0.112 0.078 DBMET02719 0.108 0.082 DBMET02716 | ||
| 0.188 | 0.019 | 0.189 | Alpha 2 adrenoreceptor antagonist | 0.189 0.019 DBMET00029 0.151 0.027 DBMET00030 0.151 0.027 DBMET01044 0.13 0.033 DBMET02714 0.104 0.045 DBMET02719 0.09 0.055 DBMET02716 | DBMET00029 | |
| 0.176 | 0.008 | 0.198 | Anabolic | 0.157 0.015 DBMET00029 0.148 0.019 DBMET02703 0.147 0.02 DBMET00032 0.184 0.006 DBMET00030 0.138 0.025 DBMET02699 0.166 0.011 DBMET01044 0.166 0.011 DBMET02714 0.105 0.055 DBMET02705 0.141 0.023 DBMET02704 0.19 0.005 DBMET00737 0.109 0.051 DBMET02702 0.146 0.02 DBMET02700 0.175 0.008 DBMET02719 0.173 0.009 DBMET02715 0.198 0.004 DBMET02716 0.153 0.016 DBMET02717 | DBMET02716 | |
| 0.177 | 0.011 | 0.274 | Thioredoxin inhibitor | 0.185 0.01 DBMET00029 0.164 0.013 DBMET00032 0.175 0.011 DBMET00030 0.15 0.017 DBMET02699 0.182 0.01 DBMET01044 0.203 0.008 DBMET02714 0.09 0.061 DBMET02705 0.13 0.025 DBMET00737 0.188 0.009 DBMET02702 0.144 0.019 DBMET02700 0.197 0.009 DBMET02719 0.232 0.005 DBMET02715 0.274 0.004 DBMET02716 0.248 0.005 DBMET02717 | DBMET02716 | |
| 0.169 | 0.004 | 0.299 | Estrogen-related receptor alpha antagonist | 0.142 0.004 DBMET00029 0.057 0.012 DBMET02703 0.124 0.005 DBMET00032 0.163 0.004 DBMET00030 0.123 0.005 DBMET02699 0.141 0.004 DBMET01044 0.154 0.004 DBMET02714 0.037 0.019 DBMET02704 0.084 0.008 DBMET00737 0.05 0.013 DBMET02702 0.089 0.007 DBMET02700 0.151 0.004 DBMET02719 0.194 0.003 DBMET02715 0.299 0.002 DBMET02716 0.078 0.008 DBMET02717 | DBMET02716 | |
| 0.19 | 0.029 | 0.271 | Cholesterol synthesis inhibitor | 0.098 0.091 DBMET00029 0.244 0.019 DBMET02703 0.236 0.02 DBMET00030 0.12 0.065 DBMET01044 0.108 0.077 DBMET02714 0.182 0.032 DBMET02705 0.184 0.031 DBMET02704 0.271 0.015 DBMET00737 0.103 0.084 DBMET02700 0.132 0.055 DBMET02719 0.182 0.032 DBMET02715 0.227 0.021 DBMET02716 0.162 0.039 DBMET02717 | DBMET00737 | |
| 0.201 | 0.042 | 0.404 | Cyclooxygenase inhibitor | 0.197 0.043 DBMET00029 0.135 0.083 DBMET00032 0.2 0.042 DBMET00030 0.173 0.055 DBMET02699 0.197 0.043 DBMET01044 0.224 0.033 DBMET02714 0.156 0.065 DBMET00737 0.152 0.069 DBMET02702 0.195 0.044 DBMET02700 0.219 0.034 DBMET02719 0.327 0.014 DBMET02715 0.404 0.007 DBMET02716 0.259 0.024 DBMET02717 | DBMET02716 | |
| 0.238 | 0.081 | 0.479 | Tyrosine 3 hydroxylase inhibitor | 0.245 0.073 DBMET00029 0.214 0.112 DBMET00032 0.286 0.04 DBMET00030 0.19 0.154 DBMET02699 0.295 0.035 DBMET01044 0.303 0.032 DBMET02714 0.363 0.013 DBMET02719 0.293 0.037 DBMET02715 0.479 0.004 DBMET02716 | DBMET02716 | |
| 0.274 | 0.119 | 0.363 | Calcium channel activator | 0.363 0.042 DBMET00029 0.273 0.121 DBMET02703 0.252 0.144 DBMET00030 0.344 0.054 DBMET01044 0.36 0.044 DBMET02714 0.341 0.056 DBMET02719 0.242 0.157 DBMET02715 0.304 0.088 DBMET02716 | DBMET00029 | |
| 0.189 | 0.039 | 0.427 | Cyclooxygenase 1 inhibitor | 0.197 0.035 DBMET00029 0.11 0.09 DBMET00032 0.203 0.033 DBMET00030 0.134 0.068 DBMET02699 0.21 0.03 DBMET01044 0.206 0.032 DBMET02714 0.194 0.037 DBMET00737 0.154 0.054 DBMET02702 0.221 0.027 DBMET02700 0.222 0.027 DBMET02719 0.305 0.014 DBMET02715 0.427 0.006 DBMET02716 0.233 0.025 DBMET02717 | DBMET02716 | |
| 0.212 | 0.063 | 0.261 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.232 0.051 DBMET02703 0.261 0.038 DBMET00030 0.155 0.137 DBMET01044 0.168 0.11 DBMET02714 0.201 0.071 DBMET02705 0.203 0.069 DBMET02719 0.164 0.118 DBMET02715 0.239 0.048 DBMET02716 0.171 0.107 DBMET02717 | DBMET00030 | |
| 0.16 | 0.012 | 0.183 | Acetylcholine release stimulant | 0.136 0.028 DBMET00029 0.122 0.044 DBMET02703 0.099 0.091 DBMET00032 0.129 0.035 DBMET00030 0.108 0.069 DBMET01044 0.117 0.053 DBMET02714 0.155 0.014 DBMET02705 0.142 0.022 DBMET02704 0.183 0.005 DBMET00737 0.116 0.054 DBMET02702 0.117 0.054 DBMET02700 0.145 0.019 DBMET02715 0.144 0.021 DBMET02716 0.153 0.015 DBMET02717 | DBMET00737 | |
| 0.186 | 0.047 | 0.214 | Arachidonic acid antagonist | 0.124 0.121 DBMET00029 0.178 0.056 DBMET02703 0.19 0.043 DBMET00030 0.131 0.112 DBMET01044 0.145 0.094 DBMET02714 0.151 0.087 DBMET02719 0.209 0.025 DBMET02715 0.214 0.021 DBMET02716 0.155 0.082 DBMET02717 | DBMET02716 | |
| 0.143 | 0.004 | 0.153 | Phospholipase D inhibitor | 0.153 0.003 DBMET00029 0.094 0.018 DBMET02703 0.087 0.025 DBMET00032 0.135 0.004 DBMET00030 0.081 0.033 DBMET02699 0.146 0.004 DBMET01044 0.12 0.006 DBMET02714 0.09 0.022 DBMET02704 0.147 0.003 DBMET00737 0.099 0.015 DBMET02702 0.143 0.004 DBMET02700 0.108 0.01 DBMET02719 0.146 0.003 DBMET02715 0.142 0.004 DBMET02716 0.088 0.024 DBMET02717 | DBMET00029 | |
| 0.299 | 0.163 | 0.824 | Cyclophilin D inhibitor | 0.318 0.147 DBMET00029 0.326 0.141 DBMET00030 0.34 0.129 DBMET01044 0.377 0.104 DBMET02714 0.676 0.017 DBMET02705 0.245 0.219 DBMET02704 0.365 0.112 DBMET00737 0.734 0.011 DBMET02702 0.336 0.133 DBMET02700 0.392 0.096 DBMET02719 0.517 0.045 DBMET02715 0.386 0.099 DBMET02716 0.824 0.005 DBMET02717 | DBMET02717 | |
| 0.159 | 0.028 | 0.168 | Alpha 2c adrenoreceptor antagonist | 0.168 0.025 DBMET00029 0.137 0.039 DBMET00030 0.144 0.035 DBMET01044 0.129 0.043 DBMET02714 0.109 0.058 DBMET02719 0.095 0.071 DBMET02716 | DBMET00029 | |
| 0.167 | 0.037 | 0.219 | Proteasome inhibitor | 0.177 0.033 DBMET00029 0.114 0.071 DBMET00032 0.165 0.038 DBMET00030 0.117 0.067 DBMET02699 0.174 0.034 DBMET01044 0.183 0.031 DBMET02714 0.096 0.093 DBMET02700 0.181 0.032 DBMET02719 0.188 0.029 DBMET02715 0.219 0.02 DBMET02716 | DBMET02716 | |
| 0.144 | 0.016 | 0.144 | Histamine N-methyltransferase inhibitor | 0.083 0.064 DBMET00029 0.09 0.056 DBMET02703 0.141 0.018 DBMET00030 0.078 0.069 DBMET01044 0.116 0.033 DBMET02714 0.112 0.036 DBMET02719 0.092 0.053 DBMET02716 | ||
| 0.142 | 0.016 | 0.225 | Dopamine D1 antagonist | 0.098 0.025 DBMET00029 0.225 0.009 DBMET00030 0.15 0.015 DBMET01044 0.067 0.042 DBMET02714 0.099 0.025 DBMET02719 0.069 0.04 DBMET02715 0.176 0.012 DBMET02716 | DBMET00030 | |
| 0.252 | 0.126 | 0.345 | Sodium/bile acid cotransporter inhibitor | 0.306 0.074 DBMET00029 0.283 0.095 DBMET02703 0.319 0.063 DBMET00030 0.213 0.171 DBMET02699 0.345 0.043 DBMET01044 0.234 0.146 DBMET02714 0.218 0.164 DBMET02705 0.261 0.116 DBMET00737 0.295 0.084 DBMET02702 0.221 0.161 DBMET02700 0.311 0.07 DBMET02719 0.273 0.105 DBMET02715 0.324 0.058 DBMET02716 0.243 0.136 DBMET02717 | DBMET01044 | |
| 0.206 | 0.083 | 0.21 | ErbB-1 antagonist | 0.198 0.091 DBMET02703 0.21 0.079 DBMET00030 | DBMET00030 | |
| 0.15 | 0.027 | 0.15 | 5 Hydroxytryptamine 2C antagonist | 0.104 0.043 DBMET00029 0.091 0.052 DBMET00030 0.08 0.061 DBMET02714 | ||
| 0.127 | 0.006 | 0.23 | Beta 1 adrenoreceptor antagonist | 0.189 0.004 DBMET00029 0.128 0.006 DBMET02703 0.075 0.021 DBMET00032 0.154 0.005 DBMET00030 0.073 0.024 DBMET02699 0.23 0.003 DBMET01044 0.124 0.007 DBMET02714 0.051 0.045 DBMET02704 0.052 0.044 DBMET00737 0.097 0.011 DBMET02700 0.152 0.005 DBMET02719 0.15 0.005 DBMET02715 0.116 0.008 DBMET02716 | DBMET01044 | |
| 0.124 | 0.004 | 0.124 | Squalene epoxidase inhibitor | 0.085 0.008 DBMET00029 0.089 0.007 DBMET02703 0.055 0.026 DBMET00032 0.122 0.004 DBMET00030 0.107 0.005 DBMET02699 0.083 0.009 DBMET01044 0.072 0.013 DBMET02714 0.081 0.009 DBMET02705 0.058 0.023 DBMET02704 0.071 0.013 DBMET02719 0.07 0.014 DBMET02715 0.063 0.018 DBMET02716 | ||
| 0.128 | 0.009 | 0.216 | Beta adrenoreceptor antagonist | 0.172 0.005 DBMET00029 0.142 0.007 DBMET02703 0.071 0.037 DBMET00032 0.16 0.005 DBMET00030 0.07 0.038 DBMET02699 0.216 0.004 DBMET01044 0.137 0.007 DBMET02714 0.062 0.052 DBMET02704 0.059 0.058 DBMET00737 0.09 0.021 DBMET02700 0.174 0.005 DBMET02719 0.135 0.007 DBMET02715 0.116 0.011 DBMET02716 | DBMET01044 | |
| 0.225 | 0.11 | 0.434 | 5 Hydroxytryptamine uptake stimulant | 0.229 0.105 DBMET00029 0.215 0.125 DBMET00030 0.203 0.146 DBMET02699 0.218 0.12 DBMET01044 0.302 0.044 DBMET02714 0.287 0.052 DBMET02719 0.253 0.078 DBMET02715 0.434 0.009 DBMET02716 0.188 0.177 DBMET02717 | DBMET02716 | |
| 0.129 | 0.014 | 0.129 | Acetylcholine M2 receptor antagonist | 0.075 0.033 DBMET00029 0.122 0.016 DBMET00030 0.071 0.036 DBMET01044 0.054 0.05 DBMET02714 0.069 0.037 DBMET02716 | ||
| 0.124 | 0.014 | 0.124 | Dopamine uptake inhibitor | 0.121 0.014 DBMET00029 0.056 0.043 DBMET02703 0.095 0.02 DBMET00030 0.092 0.021 DBMET01044 0.071 0.03 DBMET02714 0.056 0.042 DBMET02719 0.076 0.027 DBMET02716 | ||
| 0.112 | 0.005 | 0.14 | 5 Hydroxytryptamine 1B agonist | 0.14 0.004 DBMET00029 0.079 0.013 DBMET02703 0.084 0.011 DBMET00030 0.084 0.011 DBMET02699 0.102 0.006 DBMET01044 0.12 0.005 DBMET02714 0.065 0.022 DBMET02704 0.061 0.025 DBMET00737 0.097 0.007 DBMET02700 0.089 0.009 DBMET02719 | DBMET00029 | |
| 0.155 | 0.05 | 0.339 | Cyclooxygenase 2 inhibitor | 0.142 0.06 DBMET00029 0.117 0.083 DBMET00032 0.149 0.054 DBMET00030 0.148 0.055 DBMET02699 0.138 0.063 DBMET01044 0.177 0.039 DBMET02714 0.143 0.059 DBMET00737 0.11 0.091 DBMET02702 0.158 0.048 DBMET02700 0.166 0.044 DBMET02719 0.267 0.017 DBMET02715 0.339 0.009 DBMET02716 0.21 0.028 DBMET02717 | DBMET02716 | |
| 0.177 | 0.073 | 0.177 | Lipocortins synthesis antagonist | 0.163 0.088 DBMET02703 0.176 0.074 DBMET00030 0.158 0.094 DBMET02705 0.135 0.13 DBMET02717 | ||
| 0.195 | 0.098 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.225 0.077 DBMET02703 0.198 0.095 DBMET00030 0.308 0.039 DBMET02705 0.16 0.135 DBMET02702 0.275 0.052 DBMET02717 | DBMET02705 | |
| 0.17 | 0.073 | 0.181 | Sigma receptor agonist | 0.181 0.068 DBMET00030 | DBMET00030 | |
| 0.152 | 0.057 | 0.152 | Calcium channel blocker | 0.11 0.099 DBMET00029 0.11 0.1 DBMET02703 | ||
| 0.111 | 0.016 | 0.154 | Acetylcholine M3 receptor antagonist | 0.076 0.028 DBMET00029 0.053 0.05 DBMET02703 0.154 0.011 DBMET00030 0.094 0.02 DBMET01044 0.06 0.041 DBMET02714 0.073 0.03 DBMET02719 0.058 0.044 DBMET02715 0.095 0.02 DBMET02716 | DBMET00030 | |
| 0.104 | 0.011 | 0.104 | Glycine transporter inhibitor | 0.074 0.019 DBMET00029 0.09 0.014 DBMET02703 0.058 0.026 DBMET00030 0.077 0.018 DBMET02699 0.044 0.037 DBMET02714 | ||
| 0.279 | 0.189 | 0.563 | 5 Hydroxytryptamine release inhibitor | 0.284 0.184 DBMET00029 0.324 0.14 DBMET02703 0.292 0.174 DBMET00030 0.297 0.168 DBMET01044 0.398 0.079 DBMET02714 0.304 0.16 DBMET02705 0.36 0.107 DBMET02702 0.413 0.07 DBMET02719 0.537 0.022 DBMET02715 0.493 0.035 DBMET02716 0.563 0.017 DBMET02717 | DBMET02717 | |
| 0.124 | 0.035 | 0.194 | Prolactin inhibitor | 0.081 0.079 DBMET02703 0.159 0.019 DBMET00030 0.088 0.069 DBMET02699 0.108 0.048 DBMET01044 0.087 0.071 DBMET02714 0.116 0.041 DBMET02719 0.096 0.059 DBMET02715 0.194 0.01 DBMET02716 | DBMET02716 | |
| 0.126 | 0.04 | 0.126 | Antihistaminic | 0.084 0.072 DBMET00029 | ||
| 0.207 | 0.123 | 0.207 | 5 Hydroxytryptamine 1E antagonist | 0.194 0.138 DBMET00029 0.188 0.144 DBMET00030 0.174 0.161 DBMET01044 0.201 0.13 DBMET02716 | ||
| 0.084 | 0.005 | 0.084 | GABA uptake inhibitor | 0.04 0.025 DBMET00029 0.082 0.005 DBMET02703 0.037 0.032 DBMET00032 0.078 0.005 DBMET00030 0.042 0.024 DBMET02699 0.037 0.03 DBMET01044 0.065 0.008 DBMET02714 0.06 0.01 DBMET02719 0.07 0.007 DBMET02715 0.062 0.009 DBMET02716 | ||
| 0.118 | 0.039 | 0.118 | Histamine antagonist | 0.075 0.07 DBMET00029 | ||
| 0.101 | 0.023 | 0.131 | Alpha 1d adrenoreceptor antagonist | 0.131 0.017 DBMET00029 0.066 0.037 DBMET00030 0.086 0.028 DBMET01044 0.085 0.028 DBMET02714 0.054 0.045 DBMET02719 | DBMET00029 | |
| 0.104 | 0.026 | 0.149 | Interferon agonist | 0.112 0.02 DBMET02703 0.099 0.029 DBMET00030 0.082 0.049 DBMET02714 0.149 0.01 DBMET02705 0.08 0.052 DBMET02704 0.093 0.035 DBMET00737 0.086 0.044 DBMET02702 0.078 0.055 DBMET02719 0.085 0.044 DBMET02715 0.072 0.065 DBMET02716 0.096 0.032 DBMET02717 | DBMET02705 | |
| 0.088 | 0.01 | 0.356 | Estrogen receptor alpha agonist | 0.056 0.016 DBMET00029 0.035 0.023 DBMET00032 0.168 0.005 DBMET00030 0.074 0.013 DBMET02699 0.119 0.007 DBMET01044 0.062 0.015 DBMET02714 0.059 0.015 DBMET00737 0.058 0.015 DBMET02700 0.131 0.006 DBMET02719 0.097 0.009 DBMET02715 0.356 0.003 DBMET02716 0.052 0.017 DBMET02717 | DBMET02716 | |
| 0.223 | 0.147 | 0.223 | Ca(v)3.3 blocker | |||
| 0.109 | 0.039 | 0.256 | Phosphodiesterase IV inhibitor | 0.074 0.068 DBMET00029 0.1 0.045 DBMET02714 0.256 0.007 DBMET02715 0.168 0.018 DBMET02716 | DBMET02715 | |
| 0.123 | 0.057 | 0.123 | 5 Hydroxytryptamine 2 antagonist | 0.093 0.077 DBMET00029 | ||
| 0.107 | 0.043 | 0.107 | 5 Hydroxytryptamine 2A antagonist | 0.071 0.066 DBMET00029 | ||
| 0.068 | 0.005 | 0.068 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.044 0.016 DBMET02703 0.064 0.006 DBMET00032 0.05 0.011 DBMET00030 0.034 0.03 DBMET02699 | ||
| 0.19 | 0.128 | 0.27 | Cardiotonic | 0.27 0.07 DBMET02703 0.165 0.158 DBMET02705 | DBMET02703 | |
| 0.141 | 0.079 | 0.19 | Adenylate cyclase stimulant | 0.172 0.033 DBMET00029 0.147 0.069 DBMET02703 0.158 0.05 DBMET00030 0.19 0.019 DBMET01044 0.153 0.058 DBMET02714 0.132 0.097 DBMET02704 0.136 0.088 DBMET00737 0.134 0.094 DBMET02702 0.178 0.028 DBMET02700 0.17 0.036 DBMET02719 0.147 0.068 DBMET02715 0.183 0.023 DBMET02716 0.128 0.107 DBMET02717 | DBMET01044 | |
| 0.131 | 0.069 | 0.187 | MAO inhibitor | 0.101 0.089 DBMET00029 0.162 0.055 DBMET00030 0.125 0.072 DBMET01044 0.158 0.057 DBMET02714 0.187 0.045 DBMET02719 | DBMET02719 | |
| 0.164 | 0.104 | 0.18 | MAP kinase kinase 5 inhibitor | 0.167 0.095 DBMET00029 0.151 0.149 DBMET02703 0.151 0.147 DBMET01044 0.154 0.135 DBMET02714 0.18 0.063 DBMET02715 | DBMET02715 | |
| 0.069 | 0.01 | 0.101 | Glycine transporter 1 inhibitor | 0.042 0.019 DBMET00029 0.058 0.013 DBMET02703 0.034 0.024 DBMET00030 0.101 0.005 DBMET02699 0.033 0.025 DBMET02704 | DBMET02699 | |
| 0.186 | 0.129 | 0.54 | Immunostimulant | 0.157 0.149 DBMET00029 0.21 0.114 DBMET02703 0.238 0.101 DBMET00030 0.207 0.116 DBMET01044 0.247 0.097 DBMET02714 0.54 0.024 DBMET02705 0.204 0.118 DBMET02704 0.298 0.079 DBMET00737 0.5 0.029 DBMET02702 0.166 0.142 DBMET02700 0.303 0.078 DBMET02719 0.222 0.108 DBMET02715 0.242 0.099 DBMET02716 0.528 0.025 DBMET02717 | DBMET02705 | |
| 0.138 | 0.082 | 0.182 | Ca2+-transporting ATPase inhibitor | 0.129 0.126 DBMET00029 0.141 0.071 DBMET00030 0.132 0.111 DBMET01044 0.139 0.075 DBMET02714 0.131 0.117 DBMET02705 0.142 0.065 DBMET02719 0.166 0.016 DBMET02715 0.182 0.006 DBMET02716 0.177 0.009 DBMET02717 | DBMET02716 | |
| 0.107 | 0.052 | 0.142 | Antiadrenergic | 0.142 0.038 DBMET00029 0.141 0.038 DBMET02703 0.093 0.06 DBMET00030 0.119 0.046 DBMET01044 0.08 0.071 DBMET02714 | DBMET00029 | |
| 0.081 | 0.026 | 0.179 | Adrenaline uptake inhibitor | 0.179 0.007 DBMET00029 0.172 0.008 DBMET00032 0.063 0.042 DBMET00030 0.139 0.011 DBMET01044 0.08 0.027 DBMET02700 | DBMET00029 | |
| 0.11 | 0.055 | 0.146 | MAO B inhibitor | 0.131 0.045 DBMET00030 0.082 0.074 DBMET01044 0.128 0.047 DBMET02714 0.146 0.038 DBMET02719 | DBMET02719 | |
| 0.107 | 0.053 | 0.109 | Alpha adrenoreceptor antagonist | 0.109 0.052 DBMET00029 0.079 0.073 DBMET00030 0.08 0.071 DBMET01044 | DBMET00029 | |
| 0.102 | 0.048 | 0.319 | Toll-Like receptor 3 antagonist | 0.239 0.004 DBMET00029 0.18 0.008 DBMET01044 0.319 0.003 DBMET02714 0.084 0.083 DBMET02702 0.161 0.012 DBMET02700 0.248 0.004 DBMET02719 | DBMET02714 | |
| 0.087 | 0.033 | 0.087 | Calcium channel L-type blocker | 0.066 0.057 DBMET00029 0.083 0.037 DBMET02703 | ||
| 0.125 | 0.072 | 0.418 | Cyclooxygenase 3 inhibitor | 0.118 0.08 DBMET00029 0.127 0.07 DBMET02703 0.136 0.061 DBMET00030 0.129 0.068 DBMET01044 0.15 0.048 DBMET02714 0.248 0.009 DBMET02705 0.313 0.005 DBMET02702 0.159 0.041 DBMET02719 0.198 0.019 DBMET02715 0.16 0.04 DBMET02716 0.418 0.004 DBMET02717 | DBMET02717 | |
| 0.101 | 0.049 | 0.131 | ABCA1 expression enhancer | 0.099 0.051 DBMET00029 0.101 0.049 DBMET00030 0.099 0.051 DBMET01044 0.09 0.065 DBMET02714 0.092 0.063 DBMET02719 0.119 0.031 DBMET02715 0.131 0.024 DBMET02716 | DBMET02716 | |
| 0.076 | 0.024 | 0.099 | Acyl-CoA dehydrogenase inhibitor | 0.099 0.016 DBMET02703 0.066 0.029 DBMET00030 0.059 0.034 DBMET02714 0.051 0.041 DBMET02719 0.062 0.032 DBMET02715 0.083 0.021 DBMET02716 | DBMET02703 | |
| 0.103 | 0.052 | 0.138 | Adrenaline antagonist | 0.137 0.038 DBMET00029 0.138 0.038 DBMET02703 0.09 0.06 DBMET00030 0.115 0.046 DBMET01044 0.077 0.071 DBMET02714 | DBMET02703 | |
| 0.125 | 0.075 | 0.193 | Vanilloid 1 agonist | 0.162 0.028 DBMET00029 0.112 0.109 DBMET02703 0.137 0.055 DBMET00030 0.177 0.02 DBMET01044 0.155 0.033 DBMET02714 0.121 0.085 DBMET02704 0.16 0.03 DBMET02702 0.193 0.014 DBMET02700 0.17 0.023 DBMET02719 0.153 0.035 DBMET02715 0.152 0.036 DBMET02716 0.14 0.051 DBMET02717 | DBMET02700 | |
| 0.104 | 0.055 | 0.305 | Creatine kinase inhibitor | 0.16 0.02 DBMET00030 0.112 0.047 DBMET01044 0.116 0.044 DBMET02714 0.175 0.015 DBMET02719 0.168 0.017 DBMET02715 0.305 0.004 DBMET02716 | DBMET02716 | |
| 0.068 | 0.019 | 0.107 | Thromboxane synthase inhibitor | 0.073 0.016 DBMET00029 0.068 0.019 DBMET00030 0.073 0.015 DBMET01044 0.077 0.013 DBMET02714 0.077 0.013 DBMET02719 0.107 0.005 DBMET02715 0.097 0.007 DBMET02716 | DBMET02715 | |
| 0.056 | 0.008 | 0.056 | Delayed rectifier potassium channel blocker | 0.045 0.015 DBMET00029 0.045 0.016 DBMET00030 0.036 0.028 DBMET02699 0.036 0.028 DBMET01044 0.041 0.02 DBMET02714 0.034 0.032 DBMET02716 | ||
| 0.077 | 0.029 | 0.083 | Exportin-1 inhibitor | 0.083 0.022 DBMET02703 0.076 0.031 DBMET02714 0.076 0.031 DBMET02716 | DBMET02703 | |
| 0.093 | 0.046 | 0.094 | Alpha 1 adrenoreceptor antagonist | 0.094 0.045 DBMET00029 | DBMET00029 | |
| 0.076 | 0.03 | 0.289 | Aromatase inhibitor | 0.065 0.038 DBMET00029 0.087 0.025 DBMET00030 0.129 0.016 DBMET02699 0.074 0.031 DBMET01044 0.175 0.01 DBMET02714 0.058 0.042 DBMET00737 0.201 0.008 DBMET02719 0.106 0.02 DBMET02715 0.289 0.005 DBMET02716 | DBMET02716 | |
| 0.112 | 0.069 | 0.208 | Photosensitizer | 0.119 0.059 DBMET00030 0.104 0.081 DBMET02714 0.12 0.057 DBMET02705 0.136 0.041 DBMET02702 0.111 0.07 DBMET02719 0.153 0.029 DBMET02715 0.141 0.037 DBMET02716 0.208 0.011 DBMET02717 | DBMET02717 | |
| 0.062 | 0.02 | 0.062 | Alpha 1L adrenoreceptor antagonist | 0.058 0.025 DBMET02703 0.053 0.034 DBMET00030 0.05 0.041 DBMET02704 | ||
| 0.07 | 0.03 | 0.07 | 5 Hydroxytryptamine 6 antagonist | 0.053 0.044 DBMET00029 | ||
| 0.076 | 0.036 | 0.239 | 5 Hydroxytryptamine uptake inhibitor | 0.174 0.013 DBMET00029 0.239 0.009 DBMET00032 0.103 0.025 DBMET01044 | DBMET00032 | |
| 0.087 | 0.048 | 0.087 | Acetylcholine nicotinic antagonist | 0.077 0.058 DBMET00029 | ||
| 0.051 | 0.014 | 0.059 | Diamine oxidase inhibitor | 0.053 0.013 DBMET00029 0.034 0.032 DBMET01044 0.059 0.01 DBMET02714 0.038 0.025 DBMET02719 0.045 0.018 DBMET02715 | DBMET02714 | |
| 0.102 | 0.064 | 0.156 | Nav1.1 sodium channel blocker | 0.156 0.031 DBMET02703 0.104 0.062 DBMET00030 | DBMET02703 | |
| 0.135 | 0.098 | 0.149 | Heat shock protein 70 antagonist | 0.132 0.11 DBMET02703 0.145 0.06 DBMET00030 0.135 0.094 DBMET02705 0.138 0.083 DBMET02719 0.145 0.058 DBMET02716 0.149 0.047 DBMET02717 | DBMET02717 | |
| 0.112 | 0.076 | 0.278 | Alkylator | 0.109 0.079 DBMET00029 0.132 0.058 DBMET02703 0.151 0.046 DBMET00032 0.128 0.06 DBMET00030 0.125 0.063 DBMET01044 0.278 0.014 DBMET02705 0.11 0.077 DBMET02704 0.247 0.017 DBMET02702 0.165 0.039 DBMET02717 | DBMET02705 | |
| 0.078 | 0.042 | 0.138 | Peroxisome proliferator-activated receptor gamma agonist | 0.068 0.051 DBMET00029 0.097 0.029 DBMET02703 0.072 0.048 DBMET00030 0.063 0.055 DBMET01044 0.061 0.057 DBMET02714 0.067 0.052 DBMET02705 0.138 0.016 DBMET02715 0.068 0.051 DBMET02716 | DBMET02715 | |
| 0.147 | 0.112 | 0.231 | Phospholipase C inhibitor | 0.147 0.112 DBMET02703 0.175 0.066 DBMET00030 0.145 0.116 DBMET01044 0.172 0.07 DBMET02714 0.177 0.065 DBMET00737 0.207 0.04 DBMET02719 0.231 0.03 DBMET02715 0.219 0.034 DBMET02716 0.184 0.057 DBMET02717 | DBMET02715 | |
| 0.082 | 0.048 | 0.114 | Na+ K+ transporting ATPase inhibitor | 0.086 0.045 DBMET02703 0.092 0.039 DBMET00030 0.085 0.046 DBMET02714 0.114 0.02 DBMET02705 0.105 0.027 DBMET02704 0.096 0.035 DBMET00737 0.092 0.039 DBMET02702 0.095 0.037 DBMET02719 0.068 0.062 DBMET02715 0.085 0.045 DBMET02716 0.113 0.021 DBMET02717 | DBMET02705 | |
| 0.08 | 0.047 | 0.08 | 5 Hydroxytryptamine 1 antagonist | 0.066 0.057 DBMET00029 | ||
| 0.076 | 0.043 | 0.076 | 5 Hydroxytryptamine 1A antagonist | 0.062 0.051 DBMET00029 | ||
| 0.077 | 0.046 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.091 0.04 DBMET00029 | DBMET00029 | |
| 0.057 | 0.026 | 0.117 | Plasminogen activator inhibitor antagonist | 0.062 0.023 DBMET00030 0.047 0.036 DBMET01044 0.052 0.031 DBMET02714 0.057 0.026 DBMET02719 0.091 0.012 DBMET02715 0.117 0.008 DBMET02716 | DBMET02716 | |
| 0.203 | 0.173 | 0.674 | Antithrombotic | 0.256 0.122 DBMET02703 0.223 0.15 DBMET00030 0.206 0.17 DBMET01044 0.266 0.114 DBMET02714 0.674 0.01 DBMET02705 0.35 0.064 DBMET02704 0.405 0.048 DBMET00737 0.631 0.013 DBMET02702 0.272 0.109 DBMET02700 0.286 0.098 DBMET02719 0.262 0.117 DBMET02715 0.245 0.13 DBMET02716 0.667 0.01 DBMET02717 | DBMET02705 | |
| 0.077 | 0.047 | 0.105 | Adenosine A3 receptor antagonist | 0.099 0.027 DBMET00029 0.072 0.055 DBMET00030 0.091 0.031 DBMET01044 0.085 0.037 DBMET02714 0.08 0.043 DBMET02719 0.079 0.044 DBMET02715 0.105 0.024 DBMET02716 | DBMET02716 | |
| 0.068 | 0.038 | 0.091 | Interferon inducer | 0.072 0.032 DBMET02703 0.065 0.042 DBMET00030 0.061 0.051 DBMET02714 0.091 0.016 DBMET02705 0.063 0.047 DBMET00737 0.062 0.049 DBMET02702 0.059 0.056 DBMET02719 0.066 0.042 DBMET02715 0.06 0.053 DBMET02716 0.078 0.026 DBMET02717 | DBMET02705 | |
| 0.276 | 0.247 | 0.335 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.331 0.173 DBMET00029 0.275 0.248 DBMET02714 0.269 0.258 DBMET02715 0.335 0.168 DBMET02716 | DBMET02716 | |
| 0.098 | 0.07 | 0.141 | Adenylate kinase inhibitor | 0.126 0.039 DBMET02703 0.094 0.077 DBMET00030 0.103 0.063 DBMET02714 0.095 0.076 DBMET02705 0.099 0.069 DBMET02719 0.11 0.053 DBMET02715 0.141 0.03 DBMET02716 0.117 0.047 DBMET02717 | DBMET02716 | |
| 0.038 | 0.01 | 0.065 | Dopamine autoreceptor agonist | 0.059 0.006 DBMET00029 0.042 0.009 DBMET00030 0.065 0.005 DBMET01044 0.038 0.01 DBMET02714 0.042 0.009 DBMET02719 | DBMET01044 | |
| 0.09 | 0.062 | 0.116 | Glutamate release inhibitor | 0.09 0.061 DBMET00029 0.099 0.045 DBMET02703 0.097 0.048 DBMET02714 0.116 0.025 DBMET02705 0.084 0.077 DBMET02702 0.085 0.074 DBMET02719 0.087 0.071 DBMET02715 0.101 0.042 DBMET02716 0.108 0.032 DBMET02717 | DBMET02705 | |
| 0.083 | 0.057 | 0.083 | ErbB-3 antagonist | 0.078 0.064 DBMET02703 | ||
| 0.146 | 0.12 | 0.292 | Succinate dehydrogenase inhibitor | 0.14 0.132 DBMET00029 0.144 0.124 DBMET02703 0.153 0.106 DBMET00030 0.147 0.118 DBMET01044 0.19 0.058 DBMET02714 0.199 0.05 DBMET02719 0.273 0.016 DBMET02715 0.292 0.012 DBMET02716 0.163 0.09 DBMET02717 | DBMET02716 | |
| 0.101 | 0.076 | 0.208 | GABA C receptor antagonist | 0.102 0.075 DBMET00029 0.111 0.062 DBMET00030 0.112 0.062 DBMET01044 0.191 0.015 DBMET02714 0.208 0.011 DBMET02719 0.1 0.077 DBMET02715 0.193 0.014 DBMET02716 | DBMET02719 | |
| 0.065 | 0.04 | 0.065 | Dopamine D3 antagonist | 0.06 0.045 DBMET00029 | ||
| 0.045 | 0.022 | 0.057 | Leukotriene A4 hydrolase inhibitor | 0.035 0.028 DBMET02703 0.057 0.017 DBMET02714 0.038 0.026 DBMET02719 | DBMET02714 | |
| 0.038 | 0.016 | 0.046 | Melatonin receptor 1A agonist | 0.046 0.009 DBMET00029 0.035 0.021 DBMET02714 0.035 0.02 DBMET02715 | DBMET00029 | |
| 0.056 | 0.035 | 0.066 | Epithelial sodium channel blocker | 0.056 0.035 DBMET00029 0.05 0.049 DBMET02703 0.051 0.047 DBMET00030 0.051 0.046 DBMET01044 0.066 0.021 DBMET02714 0.06 0.028 DBMET02719 0.056 0.036 DBMET02715 | DBMET02714 | |
| 0.025 | 0.005 | 0.059 | Antibiotic Anthracycline-like | 0.023 0.006 DBMET00029 0.022 0.008 DBMET02703 0.018 0.017 DBMET00032 0.028 0.004 DBMET00030 0.027 0.004 DBMET01044 0.026 0.005 DBMET02714 0.043 0.002 DBMET02705 0.042 0.002 DBMET02702 0.03 0.004 DBMET02719 0.033 0.003 DBMET02715 0.037 0.003 DBMET02716 0.059 0.001 DBMET02717 | DBMET02717 | |
| 0.063 | 0.043 | 0.084 | Nitric oxide donor | 0.066 0.039 DBMET00029 0.059 0.051 DBMET02703 0.057 0.054 DBMET00032 0.057 0.054 DBMET00030 0.06 0.048 DBMET01044 0.074 0.028 DBMET02714 0.077 0.025 DBMET02705 0.081 0.021 DBMET02702 0.067 0.037 DBMET02719 0.076 0.026 DBMET02715 0.084 0.019 DBMET02717 | DBMET02717 | |
| 0.128 | 0.109 | 0.217 | GABA C receptor rho-2 antagonist | 0.17 0.05 DBMET00029 0.132 0.102 DBMET00030 0.175 0.046 DBMET01044 0.134 0.098 DBMET02714 0.138 0.092 DBMET02719 0.14 0.088 DBMET02715 0.217 0.021 DBMET02716 | DBMET02716 | |
| 0.135 | 0.115 | 0.221 | Interleukin 6 antagonist | 0.162 0.073 DBMET02703 0.151 0.088 DBMET00030 0.171 0.063 DBMET02705 0.191 0.047 DBMET02702 0.136 0.113 DBMET02715 0.221 0.031 DBMET02717 | DBMET02717 | |
| 0.063 | 0.045 | 0.075 | Calcium channel P-type blocker | 0.075 0.02 DBMET02703 0.065 0.041 DBMET02715 | DBMET02703 | |
| 0.054 | 0.036 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | 0.058 0.028 DBMET00029 0.052 0.039 DBMET02715 0.053 0.038 DBMET02716 | DBMET00029 | |
| 0.032 | 0.015 | 0.032 | Thiazolidinedione | 0.028 0.023 DBMET02703 0.029 0.021 DBMET00030 0.028 0.025 DBMET02704 0.029 0.021 DBMET00737 0.029 0.022 DBMET02700 | ||
| 0.054 | 0.037 | 0.108 | Leukotriene B4 antagonist | 0.057 0.031 DBMET02703 0.061 0.026 DBMET00030 0.05 0.044 DBMET01044 0.051 0.042 DBMET02714 0.065 0.023 DBMET02705 0.068 0.021 DBMET00737 0.067 0.021 DBMET02702 0.058 0.03 DBMET02719 0.083 0.014 DBMET02715 0.067 0.021 DBMET02716 0.108 0.009 DBMET02717 | DBMET02717 | |
| 0.101 | 0.085 | 0.28 | Topoisomerase II inhibitor | 0.151 0.049 DBMET00032 0.155 0.047 DBMET00030 0.106 0.08 DBMET01044 0.225 0.028 DBMET02705 0.204 0.032 DBMET02702 0.112 0.074 DBMET02719 0.146 0.052 DBMET02716 0.28 0.02 DBMET02717 | DBMET02717 | |
| 0.045 | 0.029 | 0.048 | Geranyltranstransferase inhibitor | 0.042 0.033 DBMET00030 0.039 0.038 DBMET02714 0.048 0.025 DBMET02716 | DBMET02716 | |
| 0.15 | 0.137 | 0.363 | Hypolipemic | 0.206 0.089 DBMET02703 0.165 0.122 DBMET00030 0.16 0.127 DBMET02699 0.327 0.041 DBMET02705 0.282 0.055 DBMET02702 0.305 0.047 DBMET02715 0.186 0.105 DBMET02716 0.363 0.032 DBMET02717 | DBMET02717 | |
| 0.036 | 0.024 | 0.074 | Retinoid X receptor agonist | 0.04 0.022 DBMET02714 0.032 0.028 DBMET02719 0.072 0.01 DBMET02715 0.074 0.009 DBMET02716 | DBMET02716 | |
| 0.089 | 0.079 | 0.14 | Gastric antisecretory | 0.089 0.079 DBMET00029 0.104 0.061 DBMET02704 0.118 0.044 DBMET00737 0.14 0.031 DBMET02700 | DBMET02700 | |
| 0.091 | 0.082 | 0.148 | Carbonic anhydrase XV inhibitor | 0.11 0.055 DBMET00030 0.091 0.081 DBMET02699 0.118 0.048 DBMET02714 0.148 0.031 DBMET02719 0.1 0.067 DBMET02715 0.143 0.033 DBMET02716 | DBMET02719 | |
| 0.061 | 0.053 | 0.061 | Neuronal nicotinic receptor antagonist | 0.059 0.056 DBMET00029 | ||
| 0.06 | 0.051 | 0.103 | Leukotriene antagonist | 0.069 0.041 DBMET00030 0.058 0.054 DBMET02719 0.103 0.02 DBMET02715 0.089 0.027 DBMET02716 0.082 0.03 DBMET02717 | DBMET02715 | |
| 0.054 | 0.046 | 0.054 | Dopamine D4 antagonist | |||
| 0.017 | 0.011 | 0.021 | Vitamin D receptor agonist | 0.017 0.01 DBMET02703 0.017 0.011 DBMET00030 0.016 0.012 DBMET02705 0.021 0.006 DBMET02715 0.017 0.01 DBMET02716 0.016 0.013 DBMET02717 | DBMET02715 | |
| 0.057 | 0.051 | 0.057 | Bcl-xL inhibitor | 0.056 0.053 DBMET00030 | ||
| 0.057 | 0.053 | 0.057 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.044 | 0.041 | 0.044 | Benzodiazepine antagonist | |||
| 0.02 | 0.018 | 0.026 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 DBMET02703 0.022 0.015 DBMET00030 0.024 0.014 DBMET02705 0.02 0.019 DBMET02702 0.021 0.017 DBMET02715 0.024 0.013 DBMET02716 0.026 0.011 DBMET02717 | DBMET02717 | |
| 0.025 | 0.023 | 0.025 | 5 Hydroxytryptamine 1D agonist | |||
| 0.165 | 0.163 | 0.426 | Superoxide dismutase inhibitor | 0.168 0.158 DBMET00029 0.197 0.12 DBMET00030 0.202 0.116 DBMET01044 0.354 0.036 DBMET02714 0.228 0.09 DBMET00737 0.426 0.022 DBMET02719 0.299 0.051 DBMET02715 0.393 0.028 DBMET02716 | DBMET02719 | |
| 0.106 | 0.105 | 0.106 | Cytokine production inhibitor | |||
| 0.148 | 0.147 | 0.612 | Free radical scavenger | 0.274 0.059 DBMET00030 0.251 0.068 DBMET01044 0.474 0.019 DBMET02705 0.481 0.018 DBMET02702 0.273 0.059 DBMET02719 0.2 0.098 DBMET02715 0.426 0.025 DBMET02716 0.612 0.008 DBMET02717 | DBMET02717 | |
| 0.089 | 0.088 | 0.457 | DNA intercalator | 0.457 0.006 DBMET00032 0.095 0.08 DBMET00030 0.137 0.049 DBMET02705 0.103 0.071 DBMET02702 | DBMET00032 | |
| 0.099 | 0.099 | 0.286 | Aldehyde dehydrogenase inhibitor | 0.127 0.064 DBMET02703 0.138 0.055 DBMET00030 0.125 0.066 DBMET01044 0.12 0.071 DBMET02714 0.111 0.081 DBMET02705 0.106 0.088 DBMET02702 0.167 0.038 DBMET02719 0.286 0.013 DBMET02715 0.201 0.027 DBMET02716 0.166 0.039 DBMET02717 | DBMET02715 | |
| 0.07 | 0.069 | 0.07 | Histamine H1 receptor antagonist | |||
| 0.086 | 0.086 | 0.095 | Falcipain 3 inhibitor | 0.095 0.075 DBMET02716 | DBMET02716 | |
| 0.018 | 0.019 | 0.043 | Retinoid X beta receptor agonist | 0.034 0.007 DBMET02715 0.043 0.005 DBMET02716 | DBMET02716 | |
| 0.06 | 0.061 | 0.071 | Potassium channel (ATP-sensitive) blocker | 0.071 0.039 DBMET02715 | DBMET02715 | |
| 0.184 | 0.185 | 0.67 | Transcription factor NF kappa B inhibitor | 0.215 0.155 DBMET00029 0.265 0.117 DBMET00030 0.292 0.099 DBMET01044 0.216 0.154 DBMET02714 0.598 0.031 DBMET02705 0.621 0.029 DBMET02702 0.293 0.098 DBMET02719 0.249 0.128 DBMET02715 0.338 0.081 DBMET02716 0.67 0.024 DBMET02717 | DBMET02717 | |
| 0.052 | 0.054 | 0.091 | Pregnane X receptor antagonist | 0.091 0.004 DBMET02715 0.084 0.005 DBMET02716 | DBMET02715 | |
| 0.029 | 0.032 | 0.053 | Retinoid X alpha receptor agonist | 0.031 0.03 DBMET02714 0.048 0.015 DBMET02715 0.053 0.013 DBMET02716 | DBMET02716 | |
| 0.094 | 0.097 | 0.106 | Electron transport complex I inhibitor | 0.098 0.087 DBMET02703 0.098 0.088 DBMET02715 0.106 0.069 DBMET02716 | DBMET02716 | |
| 0.113 | 0.116 | 0.178 | Sphingosine 1-phosphate receptor 2 antagonist | 0.118 0.101 DBMET00029 0.114 0.113 DBMET01044 0.135 0.065 DBMET02714 0.13 0.073 DBMET02719 0.178 0.016 DBMET02715 0.161 0.028 DBMET02716 | DBMET02715 | |
| 0.053 | 0.057 | 0.149 | Gonadotropin-releasing hormone receptor agonist | 0.149 0.004 DBMET00032 0.056 0.05 DBMET00030 | DBMET00032 | |
| 0.072 | 0.076 | 0.141 | Ornithine decarboxylase inhibitor | 0.105 0.039 DBMET00029 0.082 0.065 DBMET00030 0.112 0.032 DBMET01044 0.127 0.021 DBMET02714 0.089 0.057 DBMET02702 0.135 0.017 DBMET02719 0.113 0.031 DBMET02715 0.141 0.014 DBMET02716 0.118 0.027 DBMET02717 | DBMET02716 | |
| 0.155 | 0.159 | 0.663 | Antioxidant | 0.273 0.073 DBMET00030 0.255 0.081 DBMET01044 0.164 0.148 DBMET02714 0.502 0.02 DBMET02705 0.304 0.06 DBMET00737 0.523 0.018 DBMET02702 0.232 0.094 DBMET02700 0.285 0.067 DBMET02719 0.226 0.098 DBMET02715 0.398 0.035 DBMET02716 0.663 0.007 DBMET02717 | DBMET02717 | |
| 0.034 | 0.039 | 0.07 | Retinoic acid alpha receptor agonist | 0.036 0.033 DBMET02703 0.07 0.006 DBMET02715 0.052 0.013 DBMET02716 0.036 0.034 DBMET02717 | DBMET02715 | |
| 0.077 | 0.083 | 0.129 | MAO A inhibitor | 0.089 0.072 DBMET00029 0.102 0.063 DBMET00030 0.116 0.054 DBMET01044 0.099 0.065 DBMET02714 0.129 0.048 DBMET02719 | DBMET02719 | |
| 0.044 | 0.05 | 0.058 | Cytokine production stimulant | 0.058 0.014 DBMET02714 0.052 0.025 DBMET02705 0.048 0.036 DBMET02702 0.05 0.029 DBMET02719 0.048 0.035 DBMET02715 0.054 0.02 DBMET02717 | DBMET02714 | |
| 0.085 | 0.091 | 0.128 | Phosphodiesterase 6D inhibitor | 0.101 0.05 DBMET02703 0.128 0.019 DBMET02705 0.101 0.051 DBMET02702 0.09 0.075 DBMET02715 0.088 0.082 DBMET02716 0.127 0.02 DBMET02717 | DBMET02705 | |
| 0.02 | 0.028 | 0.304 | Estrogen receptor beta agonist | 0.119 0.009 DBMET00030 0.074 0.015 DBMET01044 0.126 0.009 DBMET00737 0.05 0.019 DBMET02700 0.107 0.011 DBMET02719 0.056 0.018 DBMET02715 0.304 0.004 DBMET02716 0.097 0.012 DBMET02717 | DBMET02716 | |
| 0.116 | 0.123 | 0.221 | Phospholipase A2 inhibitor | 0.13 0.101 DBMET00030 0.183 0.052 DBMET02714 0.124 0.111 DBMET02705 0.203 0.041 DBMET02719 0.221 0.033 DBMET02715 0.154 0.071 DBMET02716 0.135 0.093 DBMET02717 | DBMET02715 | |
| 0.012 | 0.02 | 0.05 | Ileal bile acid transport inhibitor | 0.017 0.012 DBMET00030 0.024 0.007 DBMET02705 0.038 0.004 DBMET02702 0.02 0.009 DBMET02715 0.018 0.011 DBMET02716 0.05 0.004 DBMET02717 | DBMET02717 | |
| 0.021 | 0.03 | 0.055 | Vanilloid 2 agonist | 0.034 0.006 DBMET02702 0.028 0.012 DBMET02700 0.034 0.006 DBMET02716 0.055 0.003 DBMET02717 | DBMET02717 | |
| 0.033 | 0.042 | 0.059 | Oxytocin agonist | 0.044 0.028 DBMET00030 0.047 0.026 DBMET01044 0.049 0.025 DBMET02719 0.059 0.018 DBMET02716 | DBMET02716 | |
| 0.025 | 0.036 | 0.06 | Peroxisome proliferator-activated receptor delta agonist | 0.033 0.024 DBMET02703 0.06 0.01 DBMET02715 | DBMET02715 | |
| 0.018 | 0.03 | 0.022 | Vitamin D receptor antagonist | 0.022 0.016 DBMET02715 0.022 0.015 DBMET02716 0.021 0.017 DBMET02717 | DBMET02716 | |
| 0.08 | 0.092 | 0.158 | Carbonic anhydrase III inhibitor | 0.117 0.046 DBMET00030 0.09 0.075 DBMET02714 0.095 0.067 DBMET00737 0.132 0.036 DBMET02719 0.118 0.045 DBMET02715 0.158 0.026 DBMET02716 0.087 0.079 DBMET02717 | DBMET02716 | |
| 0.021 | 0.033 | 0.024 | Acid ceramidase inhibitor | 0.024 0.022 DBMET00029 | DBMET00029 | |
| 0.033 | 0.047 | 0.055 | Glycine transporter 2 inhibitor | 0.046 0.033 DBMET00030 0.041 0.038 DBMET01044 0.04 0.039 DBMET02714 0.055 0.027 DBMET02719 0.049 0.031 DBMET02716 | DBMET02719 | |
| 0.035 | 0.049 | 0.079 | Peroxisome proliferator-activated receptor alpha agonist | 0.047 0.034 DBMET02703 0.079 0.018 DBMET02715 | DBMET02715 | |
| 0.158 | 0.172 | 0.404 | Peptidyltransferase inhibitor | 0.246 0.053 DBMET00029 0.219 0.078 DBMET02703 0.203 0.096 DBMET00030 0.268 0.039 DBMET01044 0.232 0.065 DBMET02714 0.362 0.01 DBMET02705 0.391 0.008 DBMET02702 0.189 0.113 DBMET02700 0.259 0.044 DBMET02719 0.204 0.094 DBMET02715 0.191 0.111 DBMET02716 0.404 0.007 DBMET02717 | DBMET02717 | |
| 0.109 | 0.123 | 0.367 | Thrombolytic | 0.128 0.101 DBMET00030 0.23 0.039 DBMET02714 0.265 0.03 DBMET02705 0.193 0.055 DBMET02704 0.208 0.048 DBMET00737 0.275 0.028 DBMET02702 0.188 0.058 DBMET02700 0.232 0.039 DBMET02719 0.167 0.07 DBMET02715 0.147 0.084 DBMET02716 0.367 0.015 DBMET02717 | DBMET02717 | |
| 0.022 | 0.036 | 0.03 | Retinoid X gamma receptor antagonist | 0.028 0.017 DBMET02714 0.026 0.02 DBMET02719 0.03 0.013 DBMET02715 0.03 0.012 DBMET02716 | DBMET02716 | |
| 0.062 | 0.077 | 0.077 | Peroxisome proliferator-activated receptor gamma antagonist | 0.069 0.055 DBMET02703 0.077 0.038 DBMET02715 | DBMET02715 | |
| 0.051 | 0.067 | 0.085 | Acetylcholine M5 receptor agonist | 0.085 0.03 DBMET02715 | DBMET02715 | |
| 0.063 | 0.08 | 0.076 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.076 0.046 DBMET02714 0.073 0.051 DBMET02716 | DBMET02714 | |
| 0.017 | 0.034 | 0.029 | Leukotriene B4 receptor 1 antagonist | 0.029 0.019 DBMET02715 0.029 0.019 DBMET02716 0.025 0.022 DBMET02717 | DBMET02716 | |
| 0.075 | 0.092 | 0.125 | Granulocyte macrophage colony stimulating factor agonist | 0.08 0.075 DBMET00029 0.098 0.037 DBMET02714 0.094 0.044 DBMET02719 0.105 0.029 DBMET02715 0.125 0.013 DBMET02716 | DBMET02716 | |
| 0.017 | 0.034 | 0.043 | Retinoic acid receptor agonist | 0.043 0.006 DBMET02715 0.029 0.01 DBMET02716 | DBMET02715 | |
| 0.016 | 0.035 | 0.024 | Retinoid X beta receptor antagonist | 0.02 0.016 DBMET02714 0.024 0.008 DBMET02715 0.024 0.008 DBMET02716 | DBMET02716 | |
| 0.027 | 0.046 | 0.043 | Retinoid X alpha receptor antagonist | 0.032 0.028 DBMET02714 0.043 0.012 DBMET02715 0.042 0.013 DBMET02716 | DBMET02715 | |
| 0.037 | 0.057 | 0.09 | Beta 2 adrenoreceptor antagonist | 0.07 0.017 DBMET00029 0.06 0.024 DBMET02703 0.055 0.029 DBMET00030 0.09 0.009 DBMET01044 0.058 0.026 DBMET02714 0.076 0.014 DBMET02719 0.052 0.034 DBMET02715 0.048 0.039 DBMET02716 | DBMET01044 | |
| 0.014 | 0.034 | 0.785 | Urotensin II antagonist | 0.785 0.001 DBMET02699 | DBMET02699 | |
| 0.029 | 0.05 | 0.05 | Retinoid X receptor antagonist | 0.036 0.03 DBMET02714 0.049 0.013 DBMET02715 0.05 0.012 DBMET02716 | DBMET02716 | |
| 0.015 | 0.036 | 0.039 | Retinoic acid beta receptor agonist | 0.039 0.004 DBMET02715 0.024 0.008 DBMET02716 | DBMET02715 | |
| 0.065 | 0.086 | 0.188 | Androgen antagonist | 0.086 0.059 DBMET00030 0.077 0.069 DBMET01044 0.118 0.035 DBMET02715 0.188 0.015 DBMET02716 | DBMET02716 | |
| 0.073 | 0.095 | 0.12 | CC chemokine 5 receptor agonist | 0.081 0.061 DBMET00030 0.084 0.052 DBMET02704 0.089 0.038 DBMET02700 0.12 0.009 DBMET02716 | DBMET02716 | |
| 0.089 | 0.111 | 0.173 | TRPA1 agonist | 0.1 0.087 DBMET00030 0.105 0.079 DBMET01044 0.12 0.059 DBMET02700 0.108 0.075 DBMET02719 0.115 0.064 DBMET02715 0.173 0.018 DBMET02716 0.109 0.072 DBMET02717 | DBMET02716 | |
| 0.022 | 0.045 | 0.028 | Hedgehog signaling activator | 0.027 0.021 DBMET02715 0.028 0.016 DBMET02716 | DBMET02716 | |
| 0.017 | 0.04 | 0.033 | Retinoic acid gamma receptor agonist | 0.033 0.005 DBMET02715 0.028 0.008 DBMET02716 | DBMET02715 | |
| 0.067 | 0.091 | 0.111 | Glutathione S-transferase inhibitor | 0.082 0.058 DBMET02699 0.095 0.042 DBMET02714 0.095 0.042 DBMET02719 0.111 0.028 DBMET02715 0.098 0.039 DBMET02716 | DBMET02715 | |
| 0.02 | 0.047 | 0.053 | Kainate receptor 2 antagonist | 0.034 0.027 DBMET00029 0.039 0.023 DBMET02714 0.053 0.015 DBMET02716 | DBMET02716 | |
| 0.037 | 0.064 | 0.074 | Lysophosphatidic acid 3 receptor antagonist | 0.049 0.037 DBMET02714 0.074 0.012 DBMET02715 0.056 0.027 DBMET02716 | DBMET02715 | |
| 0.007 | 0.036 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 DBMET02716 | DBMET02716 | |
| 0.048 | 0.077 | 0.072 | Leukotriene C antagonist | 0.053 0.051 DBMET02719 0.072 0.012 DBMET02715 0.064 0.022 DBMET02716 | DBMET02715 | |
| 0.04 | 0.07 | 0.133 | Alpha-mannosidase inhibitor | 0.059 0.027 DBMET02703 0.096 0.007 DBMET02705 0.071 0.016 DBMET02704 0.054 0.036 DBMET00737 0.082 0.01 DBMET02702 0.055 0.034 DBMET02715 0.059 0.028 DBMET02716 0.133 0.004 DBMET02717 | DBMET02717 | |
| 0.046 | 0.076 | 0.128 | Sphingosine 1-phosphate receptor 4 agonist | 0.062 0.052 DBMET02714 0.128 0.014 DBMET02715 0.058 0.057 DBMET02716 | DBMET02715 | |
| 0.028 | 0.059 | 0.033 | Calcium-independent phospholipase A2 inhibitor | 0.033 0.027 DBMET02715 | DBMET02715 | |
| 0.034 | 0.066 | 0.041 | Histamine H1 receptor agonist | 0.041 0.037 DBMET00029 | DBMET00029 | |
| 0.053 | 0.085 | 0.106 | Aminopeptidase I inhibitor | 0.075 0.047 DBMET02703 0.07 0.054 DBMET02714 0.073 0.049 DBMET02719 0.081 0.042 DBMET02715 0.106 0.025 DBMET02716 | DBMET02716 | |
| 0.013 | 0.046 | 0.025 | Retinoid X gamma receptor agonist | 0.022 0.017 DBMET02715 0.025 0.014 DBMET02716 | DBMET02716 | |
| 0.006 | 0.039 | 0.013 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 DBMET02715 | DBMET02715 | |
| 0.156 | 0.191 | 0.236 | Nitric-oxide synthase stimulant | 0.178 0.133 DBMET00029 0.211 0.072 DBMET02703 0.169 0.154 DBMET00030 0.192 0.104 DBMET01044 0.195 0.098 DBMET02714 0.188 0.112 DBMET02705 0.191 0.105 DBMET02702 0.209 0.075 DBMET02719 0.188 0.11 DBMET02715 0.236 0.043 DBMET02716 0.234 0.045 DBMET02717 | DBMET02716 | |
| 0.087 | 0.123 | 0.496 | Alpha-N-acetylglucosaminidase inhibitor | 0.189 0.037 DBMET02703 0.105 0.095 DBMET02714 0.289 0.017 DBMET02705 0.191 0.037 DBMET02702 0.105 0.095 DBMET02719 0.269 0.02 DBMET02715 0.291 0.017 DBMET02716 0.496 0.005 DBMET02717 | DBMET02717 | |
| 0.065 | 0.101 | 0.154 | Aminopeptidase B inhibitor | 0.083 0.078 DBMET02703 0.116 0.055 DBMET02714 0.105 0.061 DBMET00737 0.127 0.049 DBMET02719 0.105 0.061 DBMET02715 0.154 0.036 DBMET02716 | DBMET02716 | |
| 0.041 | 0.077 | 0.105 | Androgen agonist | 0.053 0.052 DBMET00030 0.066 0.034 DBMET02715 0.105 0.013 DBMET02716 | DBMET02716 | |
| 0.018 | 0.054 | 0.088 | Progesterone antagonist | 0.088 0.01 DBMET02716 | DBMET02716 | |
| 0.024 | 0.061 | 0.043 | Ceramide glucosyltransferase inhibitor | 0.043 0.013 DBMET02715 | DBMET02715 | |
| 0.041 | 0.079 | 0.068 | Sphingosine 1-phosphate receptor 3 antagonist | 0.068 0.028 DBMET02715 0.053 0.05 DBMET02716 | DBMET02715 | |
| 0.016 | 0.054 | 0.026 | Lysophosphatidic acid receptor 1 agonist | 0.026 0.016 DBMET02715 0.023 0.022 DBMET02716 | DBMET02715 | |
| 0.162 | 0.201 | 0.19 | Neuropeptide Y2 antagonist | 0.174 0.172 DBMET02703 0.19 0.139 DBMET02716 | DBMET02716 | |
| 0.027 | 0.066 | 0.062 | Sphingosine 1-phosphate receptor 1 agonist | 0.046 0.024 DBMET02703 0.042 0.03 DBMET02714 0.062 0.012 DBMET02715 | DBMET02715 | |
| 0.031 | 0.071 | 0.049 | Leukotriene C4 antagonist | 0.049 0.011 DBMET02715 0.042 0.021 DBMET02716 | DBMET02715 | |
| 0.048 | 0.088 | 0.067 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.05 DBMET02714 0.067 0.041 DBMET02716 | DBMET02716 | |
| 0.113 | 0.154 | 0.167 | Pregnane X receptor agonist | 0.133 0.093 DBMET02715 0.167 0.029 DBMET02716 | DBMET02716 | |
| 0.05 | 0.093 | 0.096 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.087 0.045 DBMET00032 0.081 0.05 DBMET00030 0.067 0.065 DBMET02715 0.096 0.04 DBMET02716 | DBMET02716 | |
| 0.024 | 0.067 | 0.134 | Dopamine D5 agonist | 0.038 0.03 DBMET00030 0.039 0.029 DBMET01044 0.056 0.014 DBMET02714 0.086 0.005 DBMET02719 0.038 0.031 DBMET02715 0.134 0.003 DBMET02716 | DBMET02716 | |
| 0.013 | 0.056 | 0.034 | Prostaglandin F2 alpha agonist | 0.034 0.007 DBMET02715 0.024 0.013 DBMET02716 | DBMET02715 | |
| 0.013 | 0.056 | 0.066 | Uridine phosphorylase inhibitor | 0.03 0.018 DBMET02714 0.025 0.022 DBMET02719 0.066 0.005 DBMET02715 0.032 0.016 DBMET02716 0.049 0.009 DBMET02717 | DBMET02715 | |
| 0.028 | 0.072 | 0.142 | Mannosidase inhibitor | 0.049 0.027 DBMET02703 0.097 0.006 DBMET02705 0.06 0.016 DBMET02704 0.042 0.037 DBMET00737 0.077 0.009 DBMET02702 0.054 0.021 DBMET02715 0.046 0.03 DBMET02716 0.142 0.004 DBMET02717 | DBMET02717 | |
| 0.052 | 0.097 | 0.068 | Beta 2 adrenoreceptor agonist | 0.059 0.054 DBMET00029 0.061 0.044 DBMET00030 0.068 0.023 DBMET01044 0.059 0.056 DBMET02714 0.068 0.023 DBMET02719 0.059 0.054 DBMET02715 0.063 0.039 DBMET02716 | DBMET02719 | |
| 0.11 | 0.156 | 0.189 | Sphingosine 1-phosphate receptor 5 antagonist | 0.135 0.09 DBMET02714 0.127 0.107 DBMET02719 0.189 0.017 DBMET02715 0.158 0.049 DBMET02716 | DBMET02715 | |
| 0.07 | 0.117 | 0.128 | Lanosterol 14 alpha demethylase inhibitor | 0.1 0.055 DBMET02714 0.099 0.057 DBMET02719 0.113 0.038 DBMET02715 0.128 0.023 DBMET02716 | DBMET02716 | |
| 0.096 | 0.144 | 0.176 | DNA repair enzyme inhibitor | 0.12 0.072 DBMET00032 0.173 0.016 DBMET02705 0.176 0.015 DBMET02702 0.172 0.016 DBMET02717 | DBMET02702 | |
| 0.033 | 0.082 | 0.1 | Glucose-6-phosphate isomerase inhibitor | 0.055 0.024 DBMET02705 0.043 0.042 DBMET02702 0.069 0.013 DBMET02715 0.066 0.014 DBMET02716 0.1 0.005 DBMET02717 | DBMET02717 | |
| 0.027 | 0.076 | 0.043 | ATM kinase inhibitor | 0.043 0.014 DBMET00032 | DBMET00032 | |
| 0.047 | 0.097 | 0.063 | Protein kinase C alpha inhibitor | 0.063 0.054 DBMET00032 | DBMET00032 | |
| 0.077 | 0.128 | 0.115 | Glutamate (mGluR7) agonist | 0.115 0.036 DBMET00029 0.091 0.082 DBMET02714 | DBMET00029 | |
| 0.066 | 0.12 | 0.379 | UDP-glucose 4-epimerase inhibitor | 0.111 0.05 DBMET02703 0.252 0.013 DBMET02705 0.137 0.034 DBMET02702 0.156 0.027 DBMET02715 0.169 0.023 DBMET02716 0.379 0.007 DBMET02717 | DBMET02717 | |
| 0.021 | 0.076 | 0.042 | Vascular adhesion protein 1 inhibitor | 0.042 0.023 DBMET02714 | DBMET02714 | |
| 0.035 | 0.093 | 0.051 | Beta adrenoreceptor agonist | 0.043 0.04 DBMET00029 0.046 0.029 DBMET02703 0.043 0.041 DBMET00030 0.051 0.015 DBMET01044 0.047 0.025 DBMET02719 | DBMET01044 | |
| 0.029 | 0.086 | 0.047 | Adenylate cyclase 1 inhibitor | 0.047 0.031 DBMET02716 | DBMET02716 | |
| 0.005 | 0.064 | 0.018 | Peroxisome proliferator-activated receptor alpha antagonist | 0.018 0.017 DBMET02715 | DBMET02715 | |
| 0.063 | 0.123 | 0.318 | Triose-phosphate isomerase inhibitor | 0.096 0.052 DBMET02703 0.085 0.067 DBMET02714 0.157 0.018 DBMET02705 0.159 0.018 DBMET00737 0.1 0.048 DBMET02702 0.08 0.077 DBMET02700 0.079 0.078 DBMET02719 0.149 0.02 DBMET02715 0.149 0.02 DBMET02716 0.318 0.004 DBMET02717 | DBMET02717 | |
| 0.054 | 0.115 | 0.168 | Keratolytic | 0.072 0.062 DBMET00030 0.092 0.036 DBMET02714 0.139 0.016 DBMET02719 0.153 0.014 DBMET02715 0.168 0.012 DBMET02716 | DBMET02716 | |
| 0.047 | 0.108 | 0.081 | Telomerase inhibitor | 0.081 0.044 DBMET00032 | DBMET00032 | |
| 0.069 | 0.13 | 0.157 | GABA C receptor rho-1 antagonist | 0.097 0.066 DBMET00029 0.098 0.064 DBMET01044 0.127 0.034 DBMET02714 0.129 0.033 DBMET02719 0.089 0.08 DBMET02715 0.157 0.018 DBMET02716 | DBMET02716 | |
| 0.069 | 0.131 | 0.108 | Electrolyte absorption antagonist | 0.108 0.047 DBMET02716 | DBMET02716 | |
| 0.012 | 0.075 | 0.03 | Isoleucine-tRNA ligase inhibitor | 0.03 0.005 DBMET02715 | DBMET02715 | |
| 0.025 | 0.089 | 0.062 | Sphingosine 1-phosphate receptor agonist | 0.042 0.034 DBMET02703 0.062 0.015 DBMET02715 | DBMET02715 | |
| 0.012 | 0.077 | 0.021 | Neuraminidase (Influenza B) inhibitor | 0.021 0.014 DBMET02716 | DBMET02716 | |
| 0.029 | 0.095 | 0.381 | Alcohol oxidase inhibitor | 0.158 0.009 DBMET02714 0.334 0.004 DBMET02719 0.136 0.012 DBMET02715 0.381 0.004 DBMET02716 | DBMET02716 | |
| 0.032 | 0.103 | 0.089 | 5 Hydroxytryptamine 2A agonist | 0.089 0.02 DBMET02714 0.081 0.026 DBMET02719 | DBMET02714 | |
| 0.049 | 0.123 | 0.145 | Adrenaline agonist | 0.096 0.039 DBMET00029 0.093 0.043 DBMET02703 0.08 0.058 DBMET00030 0.145 0.016 DBMET01044 0.098 0.038 DBMET02719 | DBMET01044 | |
| 0.119 | 0.193 | 0.294 | Neurotrophic factor enhancer | 0.159 0.125 DBMET00030 0.181 0.097 DBMET01044 0.185 0.092 DBMET02702 0.177 0.102 DBMET02719 0.2 0.076 DBMET02715 0.288 0.022 DBMET02716 0.294 0.02 DBMET02717 | DBMET02717 | |
| 0.01 | 0.085 | 0.023 | Beta 1 adrenoreceptor agonist | 0.023 0.015 DBMET01044 0.023 0.016 DBMET02719 | DBMET02719 | |
| 0.043 | 0.118 | 0.059 | Immunoglobulin Fc receptor antagonist | 0.059 0.027 DBMET02716 | DBMET02716 | |
| 0.017 | 0.094 | 0.066 | Dopamine D2 agonist | 0.066 0.018 DBMET00737 0.039 0.036 DBMET02700 | DBMET00737 | |
| 0.034 | 0.111 | 0.07 | Sphingosine kinase 2 inhibitor | 0.059 0.033 DBMET02714 0.066 0.025 DBMET02719 0.061 0.031 DBMET02715 0.07 0.022 DBMET02716 | DBMET02716 | |
| 0.068 | 0.147 | 0.132 | Mucolytic | 0.101 0.076 DBMET02703 0.1 0.078 DBMET02705 0.099 0.079 DBMET02719 0.104 0.072 DBMET02715 0.123 0.052 DBMET02716 0.132 0.044 DBMET02717 | DBMET02717 | |
| 0.052 | 0.131 | 0.127 | Opioid kappa receptor antagonist | 0.078 0.06 DBMET00030 0.088 0.047 DBMET01044 0.077 0.063 DBMET02719 0.127 0.021 DBMET02716 | DBMET02716 | |
| 0.07 | 0.149 | 0.261 | Tubulin antagonist | 0.261 0.024 DBMET02703 0.145 0.06 DBMET02716 | DBMET02703 | |
| 0.014 | 0.093 | 0.037 | Free fatty acid receptor 1 antagonist | 0.037 0.019 DBMET02715 | DBMET02715 | |
| 0.106 | 0.185 | 0.21 | HERG channel blocker | 0.21 0.084 DBMET00032 | DBMET00032 | |
| 0.02 | 0.1 | 0.053 | Guanylate cyclase inhibitor | 0.04 0.033 DBMET02716 0.053 0.018 DBMET02717 | DBMET02717 | |
| 0.06 | 0.14 | 0.222 | NADH dehydrogenase inhibitor | 0.09 0.057 DBMET02703 0.187 0.012 DBMET02705 0.092 0.053 DBMET02702 0.1 0.043 DBMET02715 0.123 0.027 DBMET02716 0.222 0.009 DBMET02717 | DBMET02717 | |
| 0.025 | 0.105 | 0.118 | Protein 50S ribosomal subunit inhibitor | 0.1 0.013 DBMET02705 0.088 0.016 DBMET02702 0.118 0.01 DBMET02717 | DBMET02717 | |
| 0.058 | 0.139 | 0.131 | Breast cancer-resistant protein inhibitor | 0.099 0.057 DBMET00737 0.123 0.037 DBMET02715 0.131 0.032 DBMET02716 | DBMET02716 | |
| 0.077 | 0.158 | 0.195 | Toll-Like receptor 2 antagonist | 0.109 0.091 DBMET00030 0.138 0.061 DBMET01044 0.125 0.073 DBMET02714 0.173 0.038 DBMET02719 0.134 0.065 DBMET02715 0.195 0.026 DBMET02716 | DBMET02716 | |
| 0.031 | 0.113 | 0.231 | Phosphofructokinase-1 inhibitor | 0.113 0.027 DBMET02705 0.08 0.041 DBMET02702 0.105 0.03 DBMET02715 0.123 0.024 DBMET02716 0.231 0.009 DBMET02717 | DBMET02717 | |
| 0.021 | 0.103 | 0.094 | Beta tubulin antagonist | 0.094 0.024 DBMET02716 | DBMET02716 | |
| 0.101 | 0.184 | 0.386 | Melanin inhibitor | 0.134 0.107 DBMET00030 0.129 0.116 DBMET01044 0.148 0.084 DBMET02705 0.184 0.049 DBMET02702 0.149 0.082 DBMET02719 0.167 0.062 DBMET02715 0.213 0.036 DBMET02716 0.386 0.013 DBMET02717 | DBMET02717 | |
| 0.156 | 0.239 | 0.252 | Insulysin inhibitor | 0.193 0.167 DBMET01044 0.213 0.139 DBMET02714 0.238 0.108 DBMET02719 0.252 0.095 DBMET02716 | DBMET02716 | |
| 0.043 | 0.128 | 0.064 | Ryanodine receptor antagonist | 0.064 0.029 DBMET02716 | DBMET02716 | |
| 0.016 | 0.1 | 0.036 | HMG CoA reductase inhibitor | 0.035 0.024 DBMET02703 0.033 0.026 DBMET02715 0.036 0.021 DBMET02716 0.033 0.026 DBMET02717 | DBMET02716 | |
| 0.012 | 0.097 | 0.039 | 5-Alpha-reductase inhibitor | 0.039 0.025 DBMET02716 | DBMET02716 | |
| 0.086 | 0.171 | 0.15 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.074 DBMET02703 0.15 0.026 DBMET02699 | DBMET02699 | |
| 0.01 | 0.096 | 0.103 | Sodium/glucose cotransporter 2 inhibitor | 0.071 0.004 DBMET02705 0.048 0.007 DBMET02702 0.033 0.011 DBMET02715 0.103 0.003 DBMET02717 | DBMET02717 | |
| 0.073 | 0.159 | 0.132 | Phosphodiesterase inhibitor | 0.132 0.071 DBMET02715 | DBMET02715 | |
| 0.014 | 0.103 | 0.028 | Lysophosphatidic acid 2 receptor antagonist | 0.028 0.024 DBMET02715 | DBMET02715 | |
| 0.029 | 0.117 | 0.076 | Aconitate hydratase inhibitor | 0.064 0.022 DBMET02715 0.076 0.015 DBMET02716 | DBMET02716 | |
| 0.135 | 0.224 | 0.325 | Lipoxygenase inhibitor | 0.207 0.133 DBMET00030 0.212 0.128 DBMET01044 0.183 0.159 DBMET02714 0.268 0.088 DBMET02719 0.214 0.127 DBMET02715 0.325 0.059 DBMET02716 | DBMET02716 | |
| 0.129 | 0.218 | 0.639 | Hypoglycemic | 0.173 0.143 DBMET02703 0.178 0.136 DBMET00030 0.174 0.142 DBMET01044 0.197 0.115 DBMET02714 0.544 0.012 DBMET02705 0.171 0.147 DBMET02704 0.561 0.01 DBMET02702 0.248 0.078 DBMET02719 0.269 0.066 DBMET02715 0.639 0.006 DBMET02717 | DBMET02717 | |
| 0.194 | 0.284 | 0.545 | Calcium channel L-type activator | 0.529 0.018 DBMET00029 0.328 0.134 DBMET00030 0.545 0.014 DBMET01044 0.418 0.069 DBMET02702 0.446 0.053 DBMET02700 0.361 0.109 DBMET02719 0.257 0.197 DBMET02715 0.433 0.06 DBMET02716 | DBMET01044 | |
| 0.061 | 0.152 | 0.087 | Nitric-oxide synthase inhibitor | 0.087 0.084 DBMET00029 | DBMET00029 | |
| 0.046 | 0.137 | 0.093 | Myeloperoxidase inhibitor | 0.076 0.075 DBMET01044 0.084 0.059 DBMET02714 0.093 0.044 DBMET02719 | DBMET02719 | |
| 0.024 | 0.117 | 0.137 | Opioid delta receptor antagonist | 0.053 0.051 DBMET00030 0.059 0.047 DBMET01044 0.069 0.041 DBMET02719 0.137 0.022 DBMET02716 | DBMET02716 | |
| 0.002 | 0.096 | 0.013 | Antibiotic Macrolide-like | 0.013 0.01 DBMET02717 | DBMET02717 | |
| 0.042 | 0.136 | 0.085 | Glutamate (mGluR7) antagonist | 0.085 0.022 DBMET02716 | DBMET02716 | |
| 0.043 | 0.138 | 0.103 | Glutamate dehydrogenase inhibitor | 0.069 0.058 DBMET02714 0.071 0.055 DBMET02719 0.065 0.064 DBMET02715 0.103 0.029 DBMET02716 0.074 0.052 DBMET02717 | DBMET02716 | |
| 0.081 | 0.176 | 0.359 | Protein kinase stimulant | 0.121 0.092 DBMET01044 0.111 0.103 DBMET02714 0.241 0.029 DBMET02702 0.147 0.07 DBMET02719 0.206 0.04 DBMET02715 0.194 0.044 DBMET02716 0.359 0.011 DBMET02717 | DBMET02717 | |
| 0.034 | 0.13 | 0.053 | Vanilloid 2 antagonist | 0.049 0.043 DBMET01044 0.053 0.034 DBMET02716 | DBMET02716 | |
| 0.012 | 0.11 | 0.092 | Sodium/glucose cotransporter inhibitor | 0.058 0.004 DBMET02705 0.047 0.005 DBMET02702 0.031 0.01 DBMET02715 0.092 0.003 DBMET02717 | DBMET02717 | |
| 0.012 | 0.112 | 0.046 | Kainate receptor antagonist | 0.046 0.024 DBMET02716 | DBMET02716 | |
| 0.109 | 0.209 | 0.256 | ATPase inhibitor | 0.241 0.016 DBMET02705 0.231 0.019 DBMET02702 0.137 0.126 DBMET02716 0.256 0.012 DBMET02717 | DBMET02717 | |
| 0.008 | 0.108 | 0.047 | Sphingosine 1-phosphate receptor 3 agonist | 0.047 0.018 DBMET02715 | DBMET02715 | |
| 0.011 | 0.112 | 0.055 | Protein 30S ribosomal subunit inhibitor | 0.048 0.008 DBMET02705 0.047 0.009 DBMET02702 0.055 0.007 DBMET02717 | DBMET02717 | |
| 0.018 | 0.119 | 0.052 | Ornithine carbamoyltransferase inhibitor | 0.052 0.037 DBMET02714 0.048 0.041 DBMET02719 0.048 0.041 DBMET02715 0.052 0.038 DBMET02716 | DBMET02716 | |
| 0.074 | 0.176 | 0.139 | Cathepsin H inhibitor | 0.118 0.078 DBMET02714 0.117 0.079 DBMET02715 0.139 0.055 DBMET02716 | DBMET02716 | |
| 0.027 | 0.13 | 0.082 | Carbamoyl phosphate synthetase inhibitor | 0.079 0.029 DBMET02715 0.082 0.028 DBMET02716 | DBMET02716 | |
| 0.025 | 0.129 | 0.059 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.038 0.037 DBMET02715 0.059 0.008 DBMET02716 | DBMET02716 | |
| 0.051 | 0.157 | 0.078 | Vanilloid 4 agonist | 0.078 0.045 DBMET02716 | DBMET02716 | |
| 0.007 | 0.112 | 0.025 | Telomerase stimulant | 0.018 0.011 DBMET02716 0.025 0.004 DBMET02717 | DBMET02717 | |
| 0.018 | 0.126 | 0.641 | Cholecystokinin B agonist | 0.046 0.018 DBMET02704 0.641 0.002 DBMET00737 0.354 0.003 DBMET02700 | DBMET00737 | |
| 0.031 | 0.139 | 0.13 | Catalase inhibitor | 0.13 0.031 DBMET02715 0.104 0.037 DBMET02716 | DBMET02715 | |
| 0.115 | 0.223 | 0.154 | Catenin beta inhibitor | 0.144 0.12 DBMET00030 0.154 0.096 DBMET02719 | DBMET02719 | |
| 0.136 | 0.245 | 0.277 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.165 DBMET00030 0.19 0.164 DBMET02702 0.251 0.1 DBMET02716 0.277 0.078 DBMET02717 | DBMET02717 | |
| 0.007 | 0.118 | 0.042 | Squalene synthetase inhibitor | 0.028 0.025 DBMET02705 0.042 0.017 DBMET02717 | DBMET02717 | |
| 0.012 | 0.124 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET02714 0.036 0.005 DBMET00737 0.028 0.02 DBMET02702 0.037 0.005 DBMET02700 0.031 0.014 DBMET02719 0.03 0.016 DBMET02717 | DBMET02700 | |
| 0.03 | 0.143 | 0.155 | Phenylalanine 4-hydroxylase inhibitor | 0.084 0.035 DBMET02703 0.08 0.037 DBMET01044 0.076 0.04 DBMET02714 0.118 0.019 DBMET02719 0.145 0.013 DBMET02715 0.155 0.011 DBMET02716 | DBMET02716 | |
| 0.043 | 0.158 | 0.142 | Glycine receptor antagonist | 0.078 0.06 DBMET00737 0.092 0.041 DBMET02716 0.142 0.009 DBMET02717 | DBMET02717 | |
| 0.044 | 0.159 | 0.096 | Glycine receptor agonist | 0.074 0.047 DBMET02714 0.08 0.039 DBMET02719 0.073 0.049 DBMET02715 0.096 0.023 DBMET02716 0.085 0.033 DBMET02717 | DBMET02716 | |
| 0.024 | 0.139 | 0.049 | H+/K+-transporting ATPase inhibitor | 0.049 0.038 DBMET00737 | DBMET00737 | |
| 0.098 | 0.214 | 0.18 | CF transmembrane conductance regulator agonist | 0.127 0.125 DBMET02719 0.18 0.036 DBMET02716 0.129 0.121 DBMET02717 | DBMET02716 | |
| 0.041 | 0.158 | 0.103 | Macrophage migration inhibitory factor inhibitor | 0.103 0.033 DBMET02719 0.082 0.049 DBMET02715 0.091 0.041 DBMET02716 | DBMET02719 | |
| 0.018 | 0.135 | 0.036 | Glutamate (mGluR3) agonist | 0.03 0.029 DBMET02719 0.031 0.025 DBMET02715 0.036 0.015 DBMET02716 | DBMET02716 | |
| 0.022 | 0.14 | 0.093 | Argininosuccinate synthase inhibitor | 0.051 0.046 DBMET02715 0.093 0.021 DBMET02716 0.064 0.034 DBMET02717 | DBMET02716 | |
| 0.059 | 0.178 | 0.126 | Vanilloid agonist | 0.078 0.076 DBMET00029 0.09 0.047 DBMET01044 0.113 0.022 DBMET02714 0.109 0.025 DBMET02700 0.126 0.016 DBMET02719 0.08 0.072 DBMET02716 | DBMET02719 | |
| 0.073 | 0.192 | 0.53 | Peroxidase inhibitor | 0.122 0.098 DBMET00030 0.122 0.098 DBMET01044 0.154 0.076 DBMET02714 0.334 0.031 DBMET02719 0.255 0.046 DBMET02715 0.53 0.007 DBMET02716 | DBMET02716 | |
| 0.033 | 0.152 | 0.159 | Glutamate decarboxylase inhibitor | 0.081 0.043 DBMET02714 0.114 0.023 DBMET02719 0.084 0.041 DBMET02715 0.159 0.011 DBMET02716 | DBMET02716 | |
| 0.095 | 0.214 | 0.184 | Potassium channel (Voltage-sensitive) blocker | 0.184 0.108 DBMET00032 | DBMET00032 | |
| 0.062 | 0.184 | 0.137 | Microtubule formation inhibitor | 0.132 0.049 DBMET02705 0.102 0.087 DBMET02716 0.137 0.046 DBMET02717 | DBMET02717 | |
| 0.013 | 0.134 | 0.027 | Purinergic P2Y15 antagonist | 0.027 0.024 DBMET02716 | DBMET02716 | |
| 0.026 | 0.15 | 0.066 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.055 0.04 DBMET02715 0.056 0.039 DBMET02716 0.066 0.029 DBMET02717 | DBMET02717 | |
| 0.051 | 0.177 | 0.219 | Ferrochelatase inhibitor | 0.107 0.064 DBMET02715 0.219 0.018 DBMET02716 | DBMET02716 | |
| 0.005 | 0.131 | 0.054 | Arginase inhibitor | 0.054 0.013 DBMET02717 | DBMET02717 | |
| 0.048 | 0.174 | 0.321 | Expectorant | 0.09 0.081 DBMET02703 0.21 0.018 DBMET02705 0.193 0.022 DBMET02702 0.104 0.065 DBMET02716 0.321 0.007 DBMET02717 | DBMET02717 | |
| 0.005 | 0.132 | 0.019 | Prostaglandin EP2 agonist | 0.019 0.018 DBMET02715 | DBMET02715 | |
| 0.043 | 0.17 | 0.08 | Glutamate (mGluR6) antagonist | 0.065 0.052 DBMET02714 0.072 0.035 DBMET02715 0.08 0.024 DBMET02716 | DBMET02716 | |
| 0.003 | 0.131 | 0.022 | Kainate receptor 1 antagonist | 0.022 0.014 DBMET02716 | DBMET02716 | |
| 0.024 | 0.151 | 0.05 | Kainate receptor agonist | 0.05 0.014 DBMET02716 | DBMET02716 | |
| 0.014 | 0.142 | 0.055 | Carbonic anhydrase VB inhibitor | 0.055 0.04 DBMET00737 0.052 0.043 DBMET02716 | DBMET00737 | |
| 0.01 | 0.14 | 0.037 | Fumarate hydratase inhibitor | 0.037 0.021 DBMET02716 | DBMET02716 | |
| 0.032 | 0.164 | 0.06 | NMDA receptor agonist | 0.06 0.047 DBMET02716 | DBMET02716 | |
| 0.026 | 0.158 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.045 0.042 DBMET02719 0.057 0.019 DBMET02716 | DBMET02716 | |
| 0.077 | 0.21 | 0.161 | Sphingosine 1-phosphate receptor 4 antagonist | 0.161 0.025 DBMET02715 0.117 0.078 DBMET02716 | DBMET02715 | |
| 0.011 | 0.145 | 0.024 | Thyroid hormone agonist | 0.024 0.023 DBMET02716 | DBMET02716 | |
| 0.027 | 0.161 | 0.094 | Glucose-6-phosphate translocase inhibitor | 0.065 0.019 DBMET02705 0.066 0.019 DBMET02702 0.094 0.007 DBMET02717 | DBMET02717 | |
| 0.016 | 0.151 | 0.05 | Adenosine deaminase inhibitor | 0.05 0.03 DBMET02715 0.042 0.038 DBMET02716 | DBMET02715 | |
| 0.021 | 0.156 | 0.115 | Opioid mu receptor antagonist | 0.06 0.054 DBMET02719 0.115 0.026 DBMET02716 | DBMET02716 | |
| 0.041 | 0.177 | 0.122 | Opioid antagonist | 0.08 0.068 DBMET01044 0.078 0.072 DBMET02719 0.122 0.035 DBMET02716 | DBMET02716 | |
| 0.104 | 0.241 | 0.407 | Streptokinase A inhibitor | 0.189 0.14 DBMET01044 0.188 0.141 DBMET02715 0.407 0.045 DBMET02716 | DBMET02716 | |
| 0.008 | 0.145 | 0.029 | Prostaglandin agonist | 0.029 0.024 DBMET02715 | DBMET02715 | |
| 0.028 | 0.167 | 0.216 | Porphobilinogen synthase inhibitor | 0.072 0.054 DBMET02714 0.092 0.04 DBMET02719 0.064 0.063 DBMET02715 0.216 0.01 DBMET02716 | DBMET02716 | |
| 0.055 | 0.197 | 0.121 | MAP kinase kinase 1 inhibitor | 0.089 0.072 DBMET02703 0.121 0.034 DBMET02715 | DBMET02715 | |
| 0.019 | 0.161 | 0.079 | Antibiotic Aminoglycoside-like | 0.068 0.006 DBMET02705 0.068 0.006 DBMET02702 0.079 0.004 DBMET02717 | DBMET02717 | |
| 0.048 | 0.19 | 0.196 | GABA C receptor agonist | 0.137 0.039 DBMET02714 0.135 0.041 DBMET02719 0.094 0.074 DBMET02715 0.196 0.021 DBMET02716 | DBMET02716 | |
| 0.029 | 0.172 | 0.132 | Carbonic anhydrase XIII inhibitor | 0.132 0.026 DBMET00737 0.074 0.054 DBMET02716 0.078 0.051 DBMET02717 | DBMET00737 | |
| 0.009 | 0.153 | 0.045 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.045 0.013 DBMET02716 | DBMET02716 | |
| 0.036 | 0.183 | 0.112 | GABA aminotransferase inhibitor | 0.083 0.042 DBMET02719 0.112 0.019 DBMET02716 0.1 0.027 DBMET02717 | DBMET02716 | |
| 0.048 | 0.195 | 0.096 | GABA B receptor agonist | 0.077 0.047 DBMET02714 0.092 0.024 DBMET02719 0.07 0.069 DBMET02715 0.096 0.02 DBMET02716 | DBMET02716 | |
| 0.04 | 0.191 | 0.097 | Carbonic anhydrase VI inhibitor | 0.075 0.063 DBMET02719 0.097 0.041 DBMET02716 | DBMET02716 | |
| 0.022 | 0.174 | 0.036 | Vanilloid 3 antagonist | 0.036 0.034 DBMET02716 | DBMET02716 | |
| 0.027 | 0.18 | 0.064 | Sphingosine kinase inhibitor | 0.054 0.051 DBMET02719 0.055 0.049 DBMET02715 0.064 0.033 DBMET02716 | DBMET02716 | |
| 0.015 | 0.171 | 0.058 | Xanthine dehydrogenase inhibitor | 0.058 0.04 DBMET02715 | DBMET02715 | |
| 0.119 | 0.276 | 0.186 | Gastrin inhibitor | 0.186 0.171 DBMET00029 0.186 0.17 DBMET02716 | DBMET02716 | |
| 0.023 | 0.182 | 0.096 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.054 0.047 DBMET02719 0.096 0.018 DBMET02716 0.094 0.019 DBMET02717 | DBMET02716 | |
| 0.03 | 0.189 | 0.1 | Purinergic P2X1 antagonist | 0.1 0.017 DBMET02716 | DBMET02716 | |
| 0.016 | 0.175 | 0.035 | Toll-Like receptor 4 agonist | 0.035 0.007 DBMET02705 0.029 0.013 DBMET00737 0.03 0.011 DBMET02702 0.026 0.02 DBMET02700 0.034 0.008 DBMET02717 | DBMET02705 | |
| 0.01 | 0.17 | 0.05 | Factor Xa inhibitor | 0.05 0.029 DBMET00737 0.041 0.036 DBMET02700 | DBMET00737 | |
| 0.081 | 0.244 | 0.37 | Interleukin agonist | 0.184 0.135 DBMET02714 0.32 0.039 DBMET02705 0.265 0.068 DBMET02702 0.18 0.139 DBMET02719 0.174 0.145 DBMET02715 0.235 0.09 DBMET02716 0.37 0.024 DBMET02717 | DBMET02717 | |
| 0.04 | 0.205 | 0.15 | Mediator release inhibitor | 0.119 0.049 DBMET02705 0.127 0.041 DBMET02702 0.15 0.028 DBMET02717 | DBMET02717 | |
| 0.087 | 0.252 | 0.343 | Interferon gamma antagonist | 0.171 0.056 DBMET02705 0.19 0.045 DBMET02702 0.147 0.082 DBMET02715 0.185 0.047 DBMET02716 0.343 0.015 DBMET02717 | DBMET02717 | |
| 0.104 | 0.27 | 0.183 | Neurotensin receptor agonist | 0.151 0.1 DBMET01044 0.142 0.123 DBMET02714 0.162 0.075 DBMET02719 0.183 0.046 DBMET02716 | DBMET02716 | |
| 0.004 | 0.171 | 0.01 | Purinergic P2Y2 agonist | 0.01 0.009 DBMET02717 | DBMET02717 | |
| 0.049 | 0.217 | 0.151 | DNA polymerase I inhibitor | 0.144 0.052 DBMET02705 0.121 0.067 DBMET02702 0.107 0.079 DBMET02716 0.151 0.048 DBMET02717 | DBMET02717 | |
| 0.12 | 0.289 | 0.251 | RNA-directed DNA polymerase inhibitor | 0.178 0.136 DBMET00737 0.204 0.094 DBMET02715 0.251 0.048 DBMET02716 0.214 0.081 DBMET02717 | DBMET02716 | |
| 0.017 | 0.188 | 0.057 | Neuraminidase (Influenza A) inhibitor | 0.05 0.024 DBMET02705 0.049 0.025 DBMET02702 0.044 0.034 DBMET02719 0.057 0.015 DBMET02717 | DBMET02717 | |
| 0.044 | 0.215 | 0.228 | Cystathionine beta-synthase inhibitor | 0.094 0.084 DBMET02719 0.097 0.081 DBMET02715 0.228 0.019 DBMET02716 0.185 0.028 DBMET02717 | DBMET02716 | |
| 0.096 | 0.268 | 0.162 | Calpain inhibitor | 0.162 0.161 DBMET02716 | DBMET02716 | |
| 0.036 | 0.209 | 0.168 | 5-Lipoxygenase inhibitor | 0.168 0.032 DBMET02716 | DBMET02716 | |
| 0.037 | 0.211 | 0.091 | Urease inhibitor | 0.091 0.078 DBMET02716 | DBMET02716 | |
| 0.046 | 0.22 | 0.195 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.093 0.061 DBMET02705 0.113 0.044 DBMET02715 0.126 0.036 DBMET02716 0.195 0.017 DBMET02717 | DBMET02717 | |
| 0.037 | 0.213 | 0.07 | Lipocortins synthesis agonist | 0.058 0.04 DBMET02705 0.059 0.038 DBMET02702 0.07 0.021 DBMET02717 | DBMET02717 | |
| 0.033 | 0.209 | 0.188 | Topoisomerase I inhibitor | 0.188 0.029 DBMET02705 0.141 0.045 DBMET02702 0.173 0.034 DBMET02717 | DBMET02705 | |
| 0.019 | 0.196 | 0.073 | Biliverdin reductase inhibitor | 0.073 0.03 DBMET02716 | DBMET02716 | |
| 0.03 | 0.209 | 0.069 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.069 0.029 DBMET02716 | DBMET02716 | |
| 0.004 | 0.187 | 0.162 | Estrone sulfatase inhibitor | 0.162 0.003 DBMET02699 0.102 0.004 DBMET00737 0.076 0.005 DBMET02700 | DBMET02699 | |
| 0.034 | 0.218 | 0.112 | Alcohol dehydrogenase inhibitor | 0.103 0.049 DBMET02715 0.112 0.041 DBMET02716 0.087 0.069 DBMET02717 | DBMET02716 | |
| 0.072 | 0.257 | 0.17 | DNA methyltransferase I inhibitor | 0.17 0.086 DBMET02717 | DBMET02717 | |
| 0.049 | 0.234 | 0.273 | Lipid peroxidase inhibitor | 0.126 0.087 DBMET00030 0.209 0.038 DBMET02705 0.206 0.039 DBMET02702 0.117 0.097 DBMET02716 0.273 0.023 DBMET02717 | DBMET02717 | |
| 0.047 | 0.233 | 0.092 | MAP kinase kinase 7 inhibitor | 0.078 0.051 DBMET02719 0.092 0.022 DBMET02716 | DBMET02716 | |
| 0.022 | 0.21 | 0.074 | Carbonic anhydrase VA inhibitor | 0.074 0.042 DBMET00737 | DBMET00737 | |
| 0.052 | 0.241 | 0.115 | D-Ala-D-Ala ligase inhibitor | 0.115 0.016 DBMET02716 | DBMET02716 | |
| 0.028 | 0.218 | 0.059 | Factor III inhibitor | 0.049 0.038 DBMET02702 0.05 0.034 DBMET02716 0.059 0.018 DBMET02717 | DBMET02717 | |
| 0.018 | 0.21 | 0.041 | Glutamate (mGluR8) agonist | 0.041 0.021 DBMET02716 | DBMET02716 | |
| 0.026 | 0.226 | 0.114 | Topoisomerase II alpha inhibitor | 0.106 0.036 DBMET02705 0.094 0.043 DBMET02702 0.114 0.032 DBMET02717 | DBMET02717 | |
| 0.107 | 0.308 | 0.347 | DNA synthesis inhibitor | 0.343 0.032 DBMET02705 0.241 0.073 DBMET02702 0.2 0.123 DBMET02715 0.201 0.122 DBMET02716 0.347 0.031 DBMET02717 | DBMET02717 | |
| 0.018 | 0.219 | 0.1 | Carbonic anhydrase V inhibitor | 0.1 0.027 DBMET00737 | DBMET00737 | |
| 0.01 | 0.211 | 0.039 | Alpha 1d adrenoreceptor agonist | 0.039 0.027 DBMET02716 | DBMET02716 | |
| 0.009 | 0.212 | 0.041 | NMDA receptor subunit 3A antagonist | 0.041 0.024 DBMET02716 | DBMET02716 | |
| 0.013 | 0.218 | 0.049 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DBMET02716 | DBMET02716 | |
| 0.106 | 0.31 | 0.194 | Transcription factor STAT3 inhibitor | 0.184 0.158 DBMET02714 0.191 0.146 DBMET02719 0.194 0.142 DBMET02716 | DBMET02716 | |
| 0.014 | 0.219 | 0.061 | Carbonic anhydrase XIV inhibitor | 0.061 0.024 DBMET02717 | DBMET02717 | |
| 0.077 | 0.287 | 0.345 | Non-steroidal antiinflammatory agent | 0.175 0.091 DBMET02705 0.198 0.072 DBMET02702 0.16 0.104 DBMET02715 0.144 0.124 DBMET02716 0.345 0.02 DBMET02717 | DBMET02717 | |
| 0.012 | 0.225 | 0.057 | Alpha tubulin antagonist | 0.057 0.033 DBMET02716 | DBMET02716 | |
| 0.144 | 0.358 | 0.188 | MAP kinase kinase 3 inhibitor | 0.188 0.16 DBMET02714 | DBMET02714 | |
| 0.053 | 0.268 | 0.134 | Amyloid beta aggregation inhibitor | 0.134 0.121 DBMET02705 | DBMET02705 | |
| 0.047 | 0.266 | 0.111 | Nav1.4 sodium channel blocker | 0.111 0.061 DBMET00737 0.104 0.069 DBMET02719 | DBMET00737 | |
| 0.022 | 0.242 | 0.12 | Heparanase inhibitor | 0.078 0.007 DBMET02705 0.077 0.008 DBMET02702 0.12 0.003 DBMET02717 | DBMET02717 | |
| 0.041 | 0.261 | 0.099 | Bile acid receptor antagonist | 0.099 0.051 DBMET02716 | DBMET02716 | |
| 0.037 | 0.259 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.089 0.067 DBMET02715 0.134 0.032 DBMET02716 | DBMET02716 | |
| 0.024 | 0.246 | 0.08 | NMDA receptor antagonist | 0.08 0.066 DBMET02719 0.08 0.066 DBMET02716 | DBMET02716 | |
| 0.025 | 0.248 | 0.069 | Cathepsin G inhibitor | 0.069 0.055 DBMET00737 0.064 0.062 DBMET02716 | DBMET00737 | |
| 0.043 | 0.266 | 0.443 | Amylase inhibitor | 0.346 0.013 DBMET02705 0.188 0.048 DBMET02702 0.181 0.051 DBMET02715 0.183 0.05 DBMET02716 0.443 0.007 DBMET02717 | DBMET02717 | |
| 0.058 | 0.283 | 0.247 | Diuretic | 0.247 0.031 DBMET00737 0.166 0.064 DBMET02717 | DBMET00737 | |
| 0.04 | 0.267 | 0.148 | Xanthine oxidase inhibitor | 0.086 0.079 DBMET02705 0.085 0.08 DBMET02716 0.148 0.035 DBMET02717 | DBMET02717 | |
| 0.067 | 0.297 | 0.186 | DNA methylase inhibitor | 0.186 0.089 DBMET02705 0.183 0.091 DBMET02717 | DBMET02705 | |
| 0.018 | 0.249 | 0.087 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.07 0.022 DBMET02715 0.087 0.014 DBMET02716 | DBMET02716 | |
| 0.061 | 0.292 | 0.135 | Mannose-6-phosphate isomerase inhibitor | 0.125 0.093 DBMET02716 0.135 0.08 DBMET02717 | DBMET02717 | |
| 0.007 | 0.239 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.017 DBMET02716 | DBMET02716 | |
| 0.033 | 0.271 | 0.08 | Viral attachment inhibitor | 0.08 0.05 DBMET02704 | DBMET02704 | |
| 0.019 | 0.257 | 0.124 | Histidine decarboxylase inhibitor | 0.084 0.04 DBMET02719 0.124 0.024 DBMET02716 | DBMET02716 | |
| 0.03 | 0.269 | 0.085 | Adenine nucleotide translocase inhibitor | 0.085 0.007 DBMET02705 0.067 0.019 DBMET00737 0.058 0.032 DBMET02702 0.054 0.044 DBMET02716 0.072 0.013 DBMET02717 | DBMET02705 | |
| 0.049 | 0.289 | 0.174 | DOPA decarboxylase inhibitor | 0.104 0.068 DBMET02719 0.105 0.066 DBMET02715 0.174 0.012 DBMET02716 | DBMET02716 | |
| 0.061 | 0.302 | 0.121 | Transcription factor STAT6 inhibitor | 0.121 0.058 DBMET02716 | DBMET02716 | |
| 0.008 | 0.259 | 0.039 | ATP citrate lysase inhibitor | 0.039 0.014 DBMET02716 | DBMET02716 | |
| 0.086 | 0.34 | 0.284 | 12-Lipoxygenase inhibitor | 0.19 0.163 DBMET02719 0.284 0.089 DBMET02716 | DBMET02716 | |
| 0.044 | 0.299 | 0.178 | Toll-Like receptor 4 antagonist | 0.178 0.01 DBMET02705 0.147 0.023 DBMET02702 0.171 0.012 DBMET02717 | DBMET02705 | |
| 0.035 | 0.292 | 0.061 | Transcription factor RelA inhibitor | 0.061 0.051 DBMET02716 | DBMET02716 | |
| 0.058 | 0.315 | 0.411 | Interleukin antagonist | 0.183 0.094 DBMET02703 0.379 0.034 DBMET02714 0.411 0.029 DBMET02719 | DBMET02719 | |
| 0.009 | 0.271 | 0.039 | Leukocyte elastase inhibitor | 0.039 0.034 DBMET00737 | DBMET00737 | |
| 0.021 | 0.283 | 0.131 | Protein-tyrosine phosphatase 1B inhibitor | 0.126 0.059 DBMET00737 0.091 0.088 DBMET02716 0.131 0.055 DBMET02717 | DBMET02717 | |
| 0.003 | 0.266 | 0.025 | Nicotinic acid receptor 1 antagonist | 0.025 0.005 DBMET02716 | DBMET02716 | |
| 0.004 | 0.273 | 0.537 | Cholecystokinin A agonist | 0.537 0.002 DBMET00737 0.141 0.003 DBMET02700 | DBMET00737 | |
| 0.005 | 0.275 | 0.04 | Estradiol 17 beta-dehydrogenase inhibitor | 0.04 0.031 DBMET02716 | DBMET02716 | |
| 0.023 | 0.295 | 0.049 | Parathyroid hormone antagonist | 0.049 0.024 DBMET02714 0.043 0.037 DBMET02719 | DBMET02714 | |
| 0.026 | 0.299 | 0.048 | Alpha 1b adrenoreceptor agonist | 0.048 0.041 DBMET00029 | DBMET00029 | |
| 0.004 | 0.28 | 0.641 | Cholecystokinin agonist | 0.641 0.002 DBMET00737 0.188 0.003 DBMET02700 | DBMET00737 | |
| 0.035 | 0.312 | 0.208 | Multidrug resistance-associated protein 1 inhibitor | 0.098 0.082 DBMET02705 0.208 0.009 DBMET00737 0.1 0.078 DBMET02700 | DBMET00737 | |
| 0.086 | 0.364 | 0.497 | Immunosuppressant | 0.456 0.045 DBMET02705 0.418 0.056 DBMET02702 0.229 0.167 DBMET02715 0.497 0.034 DBMET02717 | DBMET02717 | |
| 0.016 | 0.294 | 0.327 | Monophenol monooxygenase inhibitor | 0.121 0.061 DBMET02705 0.123 0.06 DBMET02702 0.089 0.084 DBMET02719 0.116 0.064 DBMET02715 0.149 0.047 DBMET02716 0.327 0.015 DBMET02717 | DBMET02717 | |
| 0.09 | 0.376 | 0.274 | 15-Lipoxygenase inhibitor | 0.274 0.147 DBMET02716 | DBMET02716 | |
| 0.095 | 0.381 | 0.247 | Antiobesity | 0.247 0.159 DBMET00737 0.204 0.203 DBMET02717 | DBMET00737 | |
| 0.005 | 0.291 | 0.097 | Kinesin antagonist | 0.097 0.008 DBMET00032 | DBMET00032 | |
| 0.005 | 0.291 | 0.097 | Kinesin-like protein 1 inhibitor | 0.097 0.008 DBMET00032 | DBMET00032 | |
| 0.079 | 0.371 | 0.157 | MAP kinase kinase 4 inhibitor | 0.13 0.115 DBMET02719 0.157 0.049 DBMET02716 | DBMET02716 | |
| 0.033 | 0.328 | 0.203 | Beta glucuronidase inhibitor | 0.117 0.048 DBMET02705 0.097 0.075 DBMET02702 0.091 0.086 DBMET02716 0.203 0.012 DBMET02717 | DBMET02717 | |
| 0.063 | 0.358 | 0.193 | Growth hormone agonist | 0.162 0.078 DBMET02714 0.193 0.062 DBMET02719 0.139 0.097 DBMET02716 | DBMET02719 | |
| 0.03 | 0.333 | 0.096 | 5 Hydroxytryptamine 3A agonist | 0.096 0.08 DBMET02716 | DBMET02716 | |
| 0.006 | 0.311 | 0.068 | Phosphorylase inhibitor | 0.068 0.021 DBMET02705 | DBMET02705 | |
| 0.008 | 0.316 | 0.206 | Antineoplastic antibiotic | 0.156 0.03 DBMET02705 0.119 0.039 DBMET02702 0.206 0.02 DBMET02717 | DBMET02717 | |
| 0.047 | 0.36 | 0.078 | T cell inhibitor | 0.078 0.073 DBMET02717 | DBMET02717 | |
| 0.041 | 0.363 | 0.259 | Cell wall synthesis inhibitor | 0.2 0.03 DBMET02705 0.148 0.067 DBMET00737 0.204 0.028 DBMET02702 0.259 0.014 DBMET02717 | DBMET02717 | |
| 0.011 | 0.335 | 0.37 | Selectin antagonist | 0.321 0.005 DBMET02705 0.258 0.008 DBMET02704 0.116 0.023 DBMET00737 0.314 0.005 DBMET02702 0.184 0.013 DBMET02700 0.37 0.004 DBMET02717 | DBMET02717 | |
| 0.024 | 0.358 | 0.08 | Somatostatin 1 agonist | 0.08 0.051 DBMET02719 | DBMET02719 | |
| 0.004 | 0.344 | 0.292 | Cholecystokinin A antagonist | 0.292 0.004 DBMET00737 0.102 0.008 DBMET02700 | DBMET00737 | |
| 0.055 | 0.395 | 0.43 | Hepatoprotectant | 0.398 0.013 DBMET02705 0.337 0.021 DBMET02702 0.43 0.011 DBMET02717 | DBMET02717 | |
| 0.02 | 0.366 | 0.057 | Dihydroorotate oxidase inhibitor | 0.057 0.033 DBMET02716 | DBMET02716 | |
| 0.023 | 0.374 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.091 0.054 DBMET02705 0.109 0.029 DBMET02702 0.124 0.017 DBMET02717 | DBMET02717 | |
| 0.039 | 0.393 | 0.147 | Transcription factor NF kappa B stimulant | 0.124 0.023 DBMET02705 0.128 0.022 DBMET02702 0.147 0.016 DBMET02717 | DBMET02717 | |
| 0.067 | 0.427 | 0.184 | Transcription factor STAT inhibitor | 0.184 0.162 DBMET02716 | DBMET02716 | |
| 0.044 | 0.405 | 0.407 | Antimitotic | 0.407 0.022 DBMET02703 | DBMET02703 | |
| 0.069 | 0.437 | 0.14 | Papain-like protease (SARS coronavirus) inhibitor | 0.117 0.09 DBMET01044 0.14 0.044 DBMET02716 | DBMET02716 | |
| 0.024 | 0.4 | 0.097 | Aminoacyl-tRNA synthetase inhibitor | 0.097 0.049 DBMET02699 0.086 0.065 DBMET02719 | DBMET02699 | |
| 0.033 | 0.411 | 0.732 | Angiogenesis stimulant | 0.508 0.011 DBMET02705 0.418 0.019 DBMET02704 0.336 0.037 DBMET00737 0.55 0.009 DBMET02702 0.389 0.023 DBMET02700 0.157 0.118 DBMET02719 0.137 0.131 DBMET02715 0.732 0.004 DBMET02717 | DBMET02717 | |
| 0.025 | 0.406 | 0.231 | Protein-tyrosine phosphatase inhibitor | 0.141 0.088 DBMET02699 0.141 0.088 DBMET02704 0.231 0.036 DBMET00737 0.136 0.094 DBMET02717 | DBMET00737 | |
| 0.038 | 0.424 | 0.262 | Platelet antagonist | 0.262 0.067 DBMET02705 0.207 0.096 DBMET02702 0.259 0.069 DBMET02717 | DBMET02705 | |
| 0.033 | 0.42 | 0.456 | Dual specificity phosphatase inhibitor | 0.456 0.009 DBMET02704 0.247 0.039 DBMET00737 | DBMET02704 | |
| 0.024 | 0.413 | 0.212 | AMP-activated protein kinase stimulant | 0.175 0.016 DBMET02705 0.142 0.033 DBMET02702 0.212 0.009 DBMET02717 | DBMET02717 | |
| 0.007 | 0.402 | 0.033 | Purinergic P2X3 antagonist | 0.033 0.027 DBMET02715 | DBMET02715 | |
| 0.012 | 0.41 | 0.191 | CDC25A inhibitor | 0.191 0.008 DBMET02704 0.095 0.03 DBMET00737 | DBMET02704 | |
| 0.004 | 0.409 | 0.229 | Cholecystokinin antagonist | 0.229 0.004 DBMET00737 0.068 0.015 DBMET02700 | DBMET00737 | |
| 0.027 | 0.432 | 0.169 | Pyruvate kinase inhibitor | 0.169 0.1 DBMET02716 | DBMET02716 | |
| 0.095 | 0.505 | 0.442 | Interleukin 2 agonist | 0.229 0.144 DBMET02714 0.42 0.022 DBMET02705 0.37 0.037 DBMET02702 0.274 0.094 DBMET02719 0.249 0.119 DBMET02716 0.442 0.017 DBMET02717 | DBMET02717 | |
| 0.008 | 0.421 | 0.044 | Microtubule stabilization | 0.044 0.036 DBMET02717 | DBMET02717 | |
| 0.022 | 0.441 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.073 DBMET02719 | DBMET02719 | |
| 0.042 | 0.461 | 0.266 | Hexokinase inhibitor | 0.126 0.109 DBMET02705 0.143 0.088 DBMET02716 0.266 0.014 DBMET02717 | DBMET02717 | |
| 0.068 | 0.488 | 0.61 | Antibacterial | 0.533 0.032 DBMET02705 0.562 0.026 DBMET02702 0.61 0.018 DBMET02717 | DBMET02717 | |
| 0.074 | 0.504 | 0.302 | Analgesic | 0.302 0.14 DBMET00032 | DBMET00032 | |
| 0.051 | 0.487 | 0.297 | Angiogenesis inhibitor | 0.223 0.144 DBMET02705 0.297 0.094 DBMET02704 0.246 0.126 DBMET00737 0.191 0.18 DBMET02702 0.188 0.184 DBMET02700 | DBMET02704 | |
| 0.04 | 0.477 | 0.104 | Interleukin 12 antagonist | 0.092 0.068 DBMET02702 0.098 0.058 DBMET02719 0.104 0.048 DBMET02717 | DBMET02717 | |
| 0.032 | 0.483 | 0.12 | Farnesoid X receptor antagonist | 0.12 0.105 DBMET02716 | DBMET02716 | |
| 0.004 | 0.459 | 0.023 | Dopamine D1 agonist | 0.023 0.016 DBMET02717 | DBMET02717 | |
| 0.035 | 0.501 | 0.404 | Nitric oxide antagonist | 0.316 0.037 DBMET02705 0.271 0.046 DBMET02702 0.135 0.111 DBMET02716 0.404 0.025 DBMET02717 | DBMET02717 | |
| 0.013 | 0.492 | 0.088 | Thrombin inhibitor | 0.078 0.044 DBMET00737 0.088 0.034 DBMET02700 | DBMET02700 | |
| 0.035 | 0.515 | 0.367 | Tumour necrosis factor alpha release inhibitor | 0.367 0.034 DBMET02705 0.287 0.059 DBMET02702 0.341 0.04 DBMET02717 | DBMET02705 | |
| 0.006 | 0.489 | 0.08 | Neuraminidase inhibitor | 0.072 0.032 DBMET02705 0.08 0.025 DBMET02717 | DBMET02717 | |
| 0.009 | 0.495 | 0.088 | Neuraminidase (influenza) inhibitor | 0.084 0.023 DBMET02705 0.064 0.045 DBMET02702 0.088 0.021 DBMET02717 | DBMET02717 | |
| 0.022 | 0.509 | 0.404 | Dual specificity phosphatase 3 inhibitor | 0.404 0.013 DBMET02704 0.235 0.045 DBMET00737 | DBMET02704 | |
| 0.008 | 0.507 | 0.073 | Elastase inhibitor | 0.063 0.027 DBMET00737 0.073 0.02 DBMET02700 | DBMET02700 | |
| 0.077 | 0.584 | 0.147 | CC chemokine 6 receptor antagonist | 0.131 0.068 DBMET02705 0.127 0.084 DBMET02702 0.147 0.026 DBMET02717 | DBMET02717 | |
| 0.028 | 0.556 | 0.232 | Hemostatic | 0.201 0.032 DBMET02705 0.144 0.076 DBMET00737 0.173 0.047 DBMET02702 0.232 0.024 DBMET02717 | DBMET02717 | |
| 0.003 | 0.55 | 0.174 | Cholecystokinin B antagonist | 0.174 0.004 DBMET00737 0.037 0.016 DBMET02700 | DBMET00737 | |
| 0.03 | 0.608 | 0.128 | Interleukin 4 antagonist | 0.125 0.079 DBMET02716 0.128 0.074 DBMET02717 | DBMET02717 | |
| 0.051 | 0.656 | 0.407 | Apoptosis antagonist | 0.407 0.036 DBMET02705 0.328 0.067 DBMET02702 0.395 0.04 DBMET02717 | DBMET02705 | |
| 0.016 | 0.625 | 0.242 | Alpha-glucosidase inhibitor | 0.242 0.192 DBMET02717 | DBMET02717 | |
| 0.046 | 0.656 | 0.14 | Death-associated protein kinase 2 inhibitor | 0.14 0.132 DBMET02716 | DBMET02716 | |
| 0.014 | 0.626 | 0.365 | Anticoagulant | 0.155 0.076 DBMET02705 0.285 0.031 DBMET02704 0.346 0.022 DBMET00737 0.16 0.072 DBMET02702 0.365 0.02 DBMET02700 0.188 0.058 DBMET02717 | DBMET02700 | |
| 0.018 | 0.673 | 0.215 | Insulin secretagoues | 0.175 0.051 DBMET02705 0.183 0.046 DBMET02702 0.215 0.029 DBMET02717 | DBMET02717 | |
| 0.004 | 0.698 | 0.121 | NMDA 2B receptor antagonist | 0.121 0.011 DBMET00737 | DBMET00737 | |
| 0.019 | 0.724 | 0.354 | Platelet adhesion inhibitor | 0.264 0.045 DBMET02705 0.171 0.088 DBMET00737 0.263 0.045 DBMET02702 0.354 0.019 DBMET02717 | DBMET02717 | |
| 0.008 | 0.716 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET00737 | DBMET00737 | |
| 0.007 | 0.722 | 0.094 | Cell adhesion molecule inhibitor | 0.079 0.054 DBMET02704 0.071 0.068 DBMET02700 0.094 0.039 DBMET02717 | DBMET02717 | |
| 0.004 | 0.728 | 0.068 | HIV-1 integrase (Strand Transfer) inhibitor | 0.068 0.037 DBMET00737 | DBMET00737 | |
| 0.004 | 0.73 | 0.036 | NMDA 2D receptor antagonist | 0.036 0.011 DBMET00737 | DBMET00737 | |
| 0.004 | 0.76 | 0.045 | Aldose reductase inhibitor | 0.045 0.043 DBMET02717 | DBMET02717 | |
| 0.011 | 0.77 | 0.194 | Cell adhesion inhibitor | 0.124 0.063 DBMET02705 0.136 0.055 DBMET02702 0.194 0.026 DBMET02717 | DBMET02717 | |
| 0.004 | 0.766 | 0.081 | HIV-1 integrase (3'-Processing) inhibitor | 0.081 0.033 DBMET00737 | DBMET00737 | |
| 0.007 | 0.785 | 0.097 | Uric acid excretion stimulant | 0.097 0.056 DBMET02717 | DBMET02717 | |
| 0.022 | 0.81 | 0.718 | Antiinflammatory | 0.575 0.06 DBMET02705 0.556 0.066 DBMET02702 0.718 0.028 DBMET02717 | DBMET02717 | |
| 0.011 | 0.822 | 0.102 | Factor IXa inhibitor | 0.049 0.039 DBMET02705 0.102 0.009 DBMET02704 0.068 0.021 DBMET02700 0.072 0.019 DBMET02717 | DBMET02704 | |
| 0.015 | 0.849 | 0.32 | Immunomodulator | 0.32 0.072 DBMET02705 0.201 0.163 DBMET02702 0.254 0.112 DBMET02717 | DBMET02705 | |
| 0.024 | 0.866 | 0.283 | NOS3 expression enhancer | 0.144 0.079 DBMET02705 0.14 0.083 DBMET02702 0.283 0.02 DBMET02717 | DBMET02717 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |